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The purpose of this study was to conduct an implementation evaluation study of 
Nurse Initiated and Managed Antiretroviral Therapy (NIMART) program in Primary 
Health Care (PHC) clinics in the Ugu district of KwaZulu-Natal.  
METHOD 
A quantitative non-experimental descriptive approach and evaluative design 
consisting of self-administered questionnaires was used to conduct the study to 
evaluate the availability of the latest Antiretroviral Therapy Guidelines, to evaluate 
the implementation of the Nurse Initiated and Managed Antiretroviral Therapy 
(NIMART) program and to evaluate the knowledge and practice of professional 
nurses towards the NIMART program in the 56 clinics of the Ugu district. 
Information leaflets were given to the participants and informed consent was 
obtained from each participant. The number of participants that were enrolled in 
the study was 52 because they met the inclusion criteria of working in the PHC 
clinics in the Ugu district and were trained in the NIMART course. The other 4 
participants were not trained in the NIMART course and were excluded according 
to the exclusion criteria. 
RESULTS 
The study revealed that in 98% (n=51) of the clinics in the Ugu district, nurses 
were initiating adults on ART and only 2% (n=1) were still being initiated by the 
doctor. Furthermore, the majority of respondents indicated that children were 
initiated on ART in their clinics, while some respondents reported that in their 
clinics children are still initiated by the clinic visiting doctor or hospital doctor. The 
findings indicated that 98% (n=51) of clinics have the latest ART Guidelines 
available, while only 2% (n=1) of clinics indicated that they have outdated ART 
Guidelines available in the clinic. The study revealed that most respondents knew 
the correct ART regimens, ART eligibility criteria and when blood for CD4 count 
and viral load is taken, while there were still some respondents who did not know. 
CONCLUSIONS AND RECOMMENDATIONS 
vii 
 
The District HAST Manager and clinics’ Operational Managers must ensure that 
the latest 2015 National Consolidated Guidelines for PMTCT are available in all 
the PHC clinics. More nurses should be trained in NIMART. All the nurses that are 
NIMART trained should receive mentorship after the training so that they become 
competent and confident in initiating and managing HIV-positive patients on ART. 
The findings of this study revealed that there were some gaps in nurse’s 
knowledge around ART regimens, blood tests and eligibility criteria. This study can 
be used as a baseline to evaluate all the professional nurses trained in NIMART in 
Ugu district. 
The District Training Coordinator must arrange a workshop regarding the 2015 
National Consolidated Guidelines to refresh NIMART nurses about ART regimens, 
about blood tests to be done and about the ART eligibility criteria. 
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DEFINITION OF ACRONYMS 
ACRONYMS    DEFINITION  
 
AIDS Acquired Immune Deficiency Syndrome (AIDS) is the 
clinical definition given to a life-threatening infection in 
persons whose immune systems have ceased to 
function properly as a result of infection with HIV. 
ARV / ART Antiretroviral (ARV) drugs inhibit the reproduction of 
retroviruses. The best known of this group is Human 
Immunodeficiency Virus (HIV), the causative agent of 
AIDS. Antiretroviral drugs are virustatic agents which 
block steps in the replication of the virus. The drugs are 
not curative. However, the continued use of these 
drugs, particularly in multi-drug regimens, significantly 
slows disease progression. ARV drugs are also 
referred to as Antiretroviral Therapy (ART). 
ELIGIBLE FOR ART Refers to people living with HIV for whom ART is 
indicated. 
HAART Highly Active Antiretroviral Therapy (HAART) is the 
combination of several antiretroviral drugs used to slow 
the rate at which HIV multiplies in the body. A 
combination of three or more antiretroviral drugs is 
more effective than using just one drug (monotherapy) 
to treat HIV. 
HAST HIV/AIDS, Sexually Transmitted Infection and 
Tuberculosis (HAST) is the program in the Department 
of Health that deals with HIV/AIDS and the drug 
management with Antiretroviral Therapy.  
xvi 
 
HCT HIV Counselling and Testing (HCT) is an umbrella term 
used to describe services that combine both HIV 
counselling and testing. 
HIV Human Immunodeficiency Virus (HIV) which attacks 
and may ultimately destroys the body’s natural immune 
system. 
NIMART Nurse Initiated Management of Antiretroviral Therapy 
(NIMART) is the decentralisation of ART initiation to 
primary health centres (PHCs) by professional nurses, 
from being doctor-led at hospitals, to reduce workload 
and the burden of managing uncomplicated cases at 
referral hospitals.    
PICT Provider Initiated Counselling and Testing (PICT) is 
HIV counselling and testing recommended by a health 
care provider in a clinical setting. 
PMTCT Prevention of Mother-to-Child Transmission of HIV 
program (PMTCT) aims at reducing the transmission of 
HIV/AIDS from HIV-positive women to their children to 










ABBREVIATION  TERM 
3TC    Lamuvidine 
ABC    Abacavir 
AIDS    Acquired Immune Deficiency Syndrome 
ART    Antiretroviral Therapy 
CD4    T-lymphocyte cell bearing CD4 receptors 
CHC    Community Health Centre 
CPT    Cotrimoxazole Preventive Therapy 
EFV    Efavirenz 
FDC    Fixed Dose Combination 
FTC    Emtricitabine 
HCT    HIV Counselling and Testing 
HIV    Human Immunodeficiency Virus 
INH    Isoniazid 
IPT    Isoniazid Preventive Therapy 
LPV    Lopinavir 
LPV/r    Lopinavir/Ritonavir 
PEPFAR   President’s Emergency Plan for AIDS Relief 
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PHC    Primary Health Care 
PICT    Provider Initiated Counselling and Testing 
PMTCT   Prevention of Mother-To-Child Transmission 
TDF    Tenofovir 
WHO    World Health Organization
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1. CHAPTER ONE 
INTRODUCTION AND BACKGROUND 
1.1. INTRODUCTION AND BACKGROUND TO THE STUDY 
The first Acquired Immunodeficiency Syndrome (AIDS) case was reported on 5 
June 1981, in the Morbidity and Mortality Weekly Report produced by the Center 
for Disease Control (CDC) in Atlanta in the USA. These conditions initially 
presented to a defined risk group of young homosexual men as rare diseases of 
Pneumocystis carinii pneumonia (PCP) and Kaposi’s sarcoma (a tumour that 
normally grows slowly). Later on it was noticed that these illnesses were also 
occurring in other groups, like haemophiliacs, blood transfusion recipients, and 
intravenous drug users. By 1982, AIDS cases were also being seen in 
heterosexual couples among partners and infants of those infected. Hence, the 
name: Acquired Immunodeficiency Syndrome, acronym AIDS, was agreed upon in 
July 1982.A working definition for AIDS was also formed in the very same year by 
the CDC based on clinical signs. The name AIDS described the disease 
accurately since people acquire the condition; it results in a deficiency within the 
immune system; and it is a syndrome not a single disease. Although the syndrome 
had been identified and named, the cause remained unknown and how it spread 
or which drugs were effective or should be formulated (Barlett, Gallant and 
Conradie, 2008). 
In 1983 the virus was identified by Dr. Luc Montagnier and colleagues at the 
Institute Pasteur in France, and was named Lymphadenopathy Associated Virus. 
In April 1984, Dr Robert Gallo from the National Cancer Institute in the US isolated 
the virus and called it Human T-Lymphotropic Virus Type III. It became apparent 
that the viruses were actually the same. Hence, the Health and Human Services 
then pronounced to the entire universe that both the French and USA had 
discovered what causes AIDS. Furthermore, the International Committee on 
Taxonomy of Viruses declared the name for the virus to be Human 
Immunodeficiency Virus (HIV) in 1987 (Whiteside, 2008). 
Over the three decades of the disease, many developments as well as mistakes 
have taken place. The AIDS epidemic has stimulated huge amounts of 
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international and foreign aid. Of particular interest has been the development of a 
new antiretroviral (ARV) treatment that is capable of transforming HIV infection 
into a chronic but manageable health condition (Lopez-Aldeguera, 
Aguirrebengoab, Arribasc, Ested and Kindelane, 2005). Mortality rates due to 
AIDS have fallen throughout the developed world, and even in some of the more 
privileged developing countries (UNAIDS, 2010). 
El-Sadr, Morrison, Quinn and Volberding (2012) declare that it was hard to recall 
the world as it existed in 2003 when the President’s Emergency Plan for AIDS 
Relief (PEPFAR) was first announced by President George W. Bush during his 
state of the Union Address. Millions of men, women and children around the world 
simply had no access to HIV care or treatment. Then, seemingly overnight, the 
world changed. No longer were health care workers standing by in dilapidated 
facilities bemoaning the lack of medicines and laboratory supplies. Instead, in 
many of the PEPFAR-focus countries, there was palpable vibrancy and 
unbounded excitement. Millions of persons living with HIV now had access to care 
and treatment. Millions of pregnant women could prevent transmission of HIV to 
their babies, millions were aware of their HIV status and had access to methods to 
protect themselves from acquiring or transmitting HIV. 
UNAIDS (2012) reported that despite recent advances in treatment and care 
available in most developed countries, the HIV/AIDS pandemic continued to 
spread throughout the developing world. The UNAIDS report on the global AIDS 
epidemic dated 2013 indicated that an estimated 35.3 million people were living 
with HIV/AIDS in 2012 globally. This was a decrease from previous years as more 
people were receiving the life-saving Antiretroviral Therapy. There were 2.3 million 
new HIV infections globally, showing a 33% decline in the number of new 
infections from 3.4 million in 2001. At the same time the number of AIDS deaths 
was also declining, with 1.6 million AIDS deaths in 2012, down from 2.3 million in 
2005 (UNAIDS, 2013). 
1.1.1. SOUTH AFRICAN HIV PREVALENCE AND INCIDENCE 
For 2013, Statistics South Africa (Stats SA) estimated the mid-year population as 
52.98 million (Stats SA, 2013). In 2010 there were approximately 5.5 million 
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people living with HIV in South Africa. New HIV infections have been decreasing. 
The incidence rate actually reduced by half from 2.6% in 1997 to 1.2% in 
2009(SANAC, 2011).  
There is an extensive epidemic of HIV in South Africa which is mostly transmitted 
sexually. In 2009 approximately 17.9% of adult population was living with HIV, of 
which 3.3 million were women and 334, 000 were children (National Strategic 
Plan, 2012-2016). KwaZulu-Natal is one of the most affected regions, with about a 
third of people living with HIV in South Africa living in this province (UNAIDS, 
2014). 
This epidemic drastically decreased the life expectancy of South Africans by 13 
years. In 1990 the life expectancy was 64 years and was reduced to 51 years in 
2005 (SANAC, 2011).  
1.1.2. SOUTH AFRICA VERSUS THE ENTIRE UNIVERSE 
The bulk of world’s population of people living with HIV are South Africans. One of 
every six people living with HIV in the whole world lives in South Africa (SANAC, 
2011). Although South Africa makes up only 0.7% of the world population, it 
carried 17% of the global HIV/AIDS burden in 2010 (UNICEF, 2011).  
The UNAIDS report indicates that in Sub-Saharan Africa, 25.0 million adults and 
children are living with HIV, 1.6 million adults and children are newly infected with 
HIV, with an adult prevalence of 4.7% and 1.2 million adult and child deaths are 
due to AIDS (UNAIDS, 2012). 
1.1.3. NUMBER OF AIDS-RELATED DEATHS IN SOUTH AFRICA 
The total number of deaths due to AIDS in South Africa has declined from 257 000 
in 2005 to 194000 in 2012 (UNAIDS, 2011). 
Former President Thabo Mbeki and senior politicians in his administration had 
adopted a widely publicised stance generally understood to mean that HIV does 
not cause AIDS. Dr. Manto Tshabalala-Msimang who was a Minister of Health 
then promoted alternative nutritional approaches such as immune boosters. The 
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minister under Zuma’s predecessor distrusted drugs developed to keep patients 
alive, instead promoting garlic treatments. A Harvard study of the years under 
President Thabo Mbeki, who questioned the link between HIV and AIDS, 
concluded that more than 300 000 premature deaths in South Africa could have 
been prevented had officials here acted sooner to provide drug treatments to 
AIDS patients and to prevent HIV-positive pregnant women from passing the virus 
to their children (Bryson, 2009). 
1.1.4. ARV COVERAGE IN SOUTH AFRICA 
In 2003, under intense political pressure, the government began to increase 
spending on HIV treatment and in 2009/2010 they spent R11.4 billion or 
approximately 13% of the R87 billion allocated to health in the 2009/2010 budget 
(Mukotsanjera, Mwenge and Giya, 2009). The National Department of Health 
(NDoH) set a goal, in its 2007 HIV Plan, of treating 80% of those in need of ARVs 
by 2011(Department of Health, 2007). 
South Africa has the largest antiretroviral program in the world. Despite this, in                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
2011, almost half the people in need of the antiretroviral treatment were not 
receiving it and 48% did not have access to ARVs. Given the late rollout of 
antiretrovirals in the public health system, South Africa has made impressive 
progress in scaling up access to treatment: 52% of those who need ARVs 
received them. More effort is still needed to provide for universal, reliable 
treatment (UNAIDS, 2011). 
1.1.5. PRESIDENT JACOB ZUMA’S SPEECH ON 1 DECEMBER 2009 
On 1st December 2009, President Zuma announced that South Africa was to 
embark on a massive effort to expand antiretroviral care for both adults and 
children to the primary health care facility level to ensure that all health institutions 
in the country were ready to receive and assist patients and not just a few 
accredited ARV centres. South Africa followed in the footsteps of many other 
countries, particularly those addressing a generalised HIV epidemic, which had 
begun to decentralise HIV treatment to primary health care centres with the 
ultimate goal of universal access to HIV treatment. Nurse Initiated and Managed 
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Antiretroviral Therapy (NIMART) was identified as a key strategy to obtain this 
goal (Smith, Matshikwe and Letsoalo, 2011). 
The South African National AIDS Council (SANAC, 2010) stated that on World 
AIDS day, 1st December 2009, the President announced that the following 
directives to address the HIV epidemic in South Africa would be launched on the 
1st April 2010: 
1. A massive campaign to mobilise all South Africans to get tested for HIV and 
to ensure that every South African knows their HIV status.  
2. Increased access to treatment for children under one year of age that test 
positive for HIV. This would contribute significantly towards the quality of life 
for infected children and would reduce infant mortality. 
3. Patients presenting with both TB and HIV infection would be initiated on 
Antiretroviral Therapy (ART) if their CD4 count is 350 or less, shifting from 
the old guidelines of initiating treatment when CD4 count was less than 
200. TB and HIV would be treated under one roof. While 1% of the 
population has TB, 73% have co-infection with TB and HIV. The policy 
change would support programs to reduce deaths arising from undetected 
TB infection among those living with HIV.  
4. All pregnant HIV-positive women with a CD4 count of 350 or with symptoms 
regardless of CD4 count would have access to treatment - a shift from 
eligibility for treatment when CD4 count was less than 200. 
5. All other HIV-positive, pregnant women with higher CD4 counts would be 
put on treatment at fourteen weeks of pregnancy to prevent Mother-to-Child 
transmission of HIV. 
6. All the health institutions in the country should be able to provide HIV 
counselling, testing and treatment. 
1.1.6. TASK SHIFTING 
6 
 
Task shifting refers to the practice of delegating tasks to health workers with 
subordinate qualifications. Tasks can be passed on from one group of 
professionals to another, or to workers with less training (Philips, Zachariah and 
Venis, 2008). This form of restructuring and decentralisation of health care 
systems according to task shifting can be seen to alleviate the shortage of health 
workers, especially in jurisdictions with high HIV incidence (WHO, 2007).The 
guidelines further state that it is instructive to note that task shifting is not 
advocated as a sole solution to human resource deficits, as it is universally 
emphasised that other methods to address this issue need to be deployed in 
addition to task shifting. 
The World Health Organization, together with UNAIDS and President’s 
Emergency Plan for AIDS Relief (PEPFAR) formulated recommendations and 
guidelines on task shifting with a view to enhancing access to HIV treatment. The 
National Department of Health’s policy response will be set out hereunder, 
together with the WHO guidelines, as a means to analyse the response to such 
recommendations and to depict the local response to task shifting (El-Khatib and 
Richter, 2009). Since then, task shifting has proven to reinforce maintaining 
patients on ARVs, as well as to reduce the burden of managing uncomplicated 
cases at hospitals (Nyasulu, Muchiri, Mazwi and Rasetshefola, 2013). 
The Department of Health indicated that it recognised the weaknesses in the 
healthcare system, and devised a ten point plan as part of its strategy to improve 
healthcare delivery. Aspects of the plan include improving the management of 
resources and human resource development and management (Department of 
Health, 2010). Furthermore, in order to remedy the misdistribution of health 
workers between urban and rural areas and between the private and public 
sectors, health professionals such as doctors, pharmacists and dieticians are 
required to engage in one year of community service in a designated area (Health 
Professions Act, 1974). 




In December 2009, the South African government set ambitious goals of testing 
15 million people for HIV and expanding ART initiation to 2000 PHC facilities that 
previously could not offer this service. This required a drastic increase in the 
number of nurses trained in Nurse Initiated and Managed Antiretroviral Therapy 
(NIMART). A policy designed to expand HIV treatment and care through task 
shifting from the sparse quantity of physicians to the stronger cadre of nurses 
(Istre, 2011). By the end of 2009, it was estimated that about 1.2 million people 
would need to be initiated on ART over the following two years, which would have 
exceeded the capacity of the health care system if treatment were to be managed 
by the cadre of doctors only (Nyasulu et al., 2013). Hence, task shifting to nurse-
managed care in primary care settings was essential. From April 2010, nurses 
began initiating ARVs to patients after they had received NIMART training, in order 
to bridge the gap between knowledge and practice (Erasmus, 2013). According to 
Nyasulu et al. (2013), patients had the advantage of fetching ARVs at their local 
clinics due to NIMART, thus saving time and transport expenses. 
The World Health Organization has encouraged the task of primary health care 
and community-driven care in the distribution of ARVs in remote areas(WHO, 
2006). Lesotho has authorised nurses to initiate ARVs since 2006 and it was 
incorporated officially into the Lesotho Treatment Guidelines in 2008. However 
many countries in Southern Africa have been hesitant to endorse nurse initiation 
of Antiretroviral Therapy regardless of the fact that it is recommended by the 
World Health Organization (Ministry of Health and Social Welfare, 2008). 
1.2. PROBLEM STATEMENT 
The 2013UNAIDS report on the global AIDS epidemic (UNAIDS, 2013) indicated 
that more people living with HIV/AIDS were accessing the antiretroviral treatment. 
UNAIDS (2013) reported that, as of December 2012, approximately 9.7 million 
people in low- and middle-income countries were receiving Antiretroviral Therapy, 
which was an increase of 1.6 million from 2011. That brought the world nearly two 
thirds of the way towards the 2015 target of 15 million people accessing 
Antiretroviral Therapy. However, there were others who should have been 
receiving the treatment but did not have access to ARVs due to an inadequate 
number of doctors in the public sector. As a result some patients were initiated on 
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ARVs late and others died prematurely before they could even access the 
treatment. Hence, there was a great need for expanding the antiretroviral 
treatment to the primary health care level.  
Bryson (2009) states that President Jacob Zuma said in his speech people would 
live longer, more fulfilling and healthy lives. The new steps included treatment for 
all HIV-positive children under one year old; earlier treatment for patients infected 
with both viruses that cause AIDS and tuberculosis; and earlier treatment for 
women who are pregnant and HIV-positive. He said all health institutions, not just 
specialist centres, would provide counselling, testing and treatment. 
Hence, the doctor-driven distribution of ART was identified as inappropriate in 
developing countries with a high HIV burden and restricted healthcare personnel. 
Consequently, the implementation of HIV treatment policies had been hindered 
(Erasmus, 2013). In 2010, there was a presidential mandate that public health 
facilities should make ARVs available and that nurses should be trained to 
prescribe and manage patients on these drugs. By April 2011, 2552 health 
facilities were initiating patients on ART (Nyasulu et al. 2013). The implementation 
of NIMART thus enhanced access to ART and has been incredibly worthwhile 
(Erasmus, 2013). 
1.3. AIM 
The aim of the study was to evaluate the implementation of the 2010 HIV/AIDS 
Guidelines in the Primary Health Care clinics in Ugu district to ensure the provision 
of HIV counselling, testing and treatment to HIV-positive patients, and to ensure 
the availability of the current guidelines on Antiretroviral Therapy. 
1.4. STUDY OBJECTIVES 
The study objectives were as follows: 
 
1. To evaluate the availability of latest Antiretroviral Therapy Guidelines in 
the Primary Health Care clinics in the Ugu district.  
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2. To evaluate the implementation of Nurse Initiated and Managed 
Antiretroviral Therapy (NIMART) program at the clinics in the Ugu 
district. 
3. To evaluate the knowledge and practice of professional nurses towards 
the NIMART program in the clinics in the Ugu district. 
 
1.5. RESEARCH QUESTIONS 
The three research questions were as follows: 
1. What guidelines are available at Primary Health Care clinics in the Ugu 
district to provide Antiretroviral Therapy for HIV-positive patients? 
2. How are the Primary Health Care facilities in the Ugu district equipped to 
provide HIV counselling, testing and treatment? 
3. What is the level of knowledge and practice of professional nurses in the 
clinics in the Ugu District towards the NIMART program?  
1.6. SIGNIFICANCE OF THE STUDY 
Nyasulu et al. (2013) pointed out that South Africa was facing a high burden of 
HIV/AIDS and millions of people living with HIV needed to be initiated on 
antiretrovirals. However, there was a gross shortage of doctors to initiate them and 
hospitals were overcrowded. Hospitals could not cope with the volume of HIV-
positive patients. A solution to this challenge was to decentralise antiretroviral care 
to Primary Health Care, so as to increase access of patients to antiretrovirals. By 
April 2011, 2552 health facilities were initiating patients on ART. Hence, 
decentralisation of services to primary health centres (PHCs) has strengthened 
retention of patients on ART, and reduced the burden of managing uncomplicated 
cases at referral hospitals (Nyasulu et al. 2013). 
This study will give an indication as to whether the Ugu district is complying with 
the presidential mandate. The information from this study can be used to 
strengthen access to antiretrovirals at PHC, thus saving patients transport costs 
and reaching more patients who are eligible for ART initiation. This information 
can also be used in the training of nurses since the district Training coordinator will 
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be able to establish the total number of nurses that are NIMART trained and the 
district training needs. Moreover, the district Training coordinator will be able to 
ascertain if NIMART trained nurses need further mentoring in order to be more 
confident in initiating patients on Antiretroviral Therapy. 
Furthermore, this information can be used by district manager for HIV/AIDS, 
Sexually Transmitted Infection and Tuberculosis (HAST) to monitor the district 
performance and improve the programme’s indicators. Lastly, the findings of this 
study will improve service delivery and the health of people.  
1.7. THEORETICAL FRAMEWORK 
1.7.1. LOGICFRAMEWORK 
A logic framework or logic model presents a linear and logical interpretation of the 
relationship between inputs, activities, outputs, outcomes and impacts with respect 
to objectives and goals. It also shows the causal relationship between inputs, 
activities, outputs, outcomes and impact. A logic framework outlines the specific 
inputs needed to carry out the activities and processes to produce specific outputs 
which will result in specific outcomes and impacts. A logic framework is also used 
for monitoring and evaluating activities throughout the stages of the program 
(Gage and Dunn, 2009). 
Gage and Dunn (2009) further state that a logic framework is presented as 
diagrams connecting program inputs to processes, outputs, outcome and impact 
as they relate to a specific problem or situation. A logic framework show what 
resources the program will need in order to accomplish its goals, what the 
program will do, and what it hopes to achieve, emphasising links between these 
aspects. A series of “if-then” relationships connects the components of the logic 
framework, if resources are available to the program, then program activities can 
be implemented. If program activities are implemented successfully, then certain 
outputs and outcomes can be expected. 
Unlike a conceptual framework, the logic framework does not try to account for all 
the factors that may influence a program’s operation and results. Instead, the logic 
framework focuses on the program’s inputs, activities, and results. This narrow 
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focus assists program managers as well as monitoring and evaluating planners as 
they clarify the direct relationships among elements of particular interest within a 
specific program (Gage and Dunn, 2009). 
1.7.2. HOW LOGIC FRAMEWORK RELATES TO THIS STUDY 
The logic framework given below represents a simple outlook of a plan intended to 
develop a health provider’s knowledge, attitudes, and practices. It is also intended 
to enhance access to comprehensive HIV counselling, testing, care and treatment 
services at community level, and hence decrease the workload at the district 
hospitals.  
Input refers to the human resources and financial resources required to develop 
the training materials and to implement the training program. 
Process in this study refers to identifying service providers who will conduct 
NIMART training and conduct mentorship training for mentors who will support the 
nurses who will be the implementers. Process also refers to conducting training for 
nurses who will be rolling out ARV’s at the PHC setting. 
Output refers to nurses trained in NIMART, and improved attitudes of NIMART 
nurses. Output also refers to the increased ability of NIMART nurses to initiate 
adult and paediatric patients to antiretroviral therapy. Furthermore, output refers to 
increased understanding and acceptance of task shifting by nurses. 
Outcome refers to competent and confident NIMART nurses, increased 
knowledge of HIV counselling, testing, care and treatment services. Output also 
refers to the decentralisation of ART and improved access to ART. 
Impact in this study refers to improved health and longevity for all. It also refers to 





















Figure 1. Logic Framework for a Health Provider Training Programme (Gage 
and Dunn, 2009) 
1.8. CONCLUSION 
The first chapter introduced the study and provided its background. The aim, study 
objectives, research questions were outlined. Significance of the study was 
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2. CHAPTER TWO:  
LITERATURE REVIEW 
2.1. INTRODUCTION 
This chapter reviews literature on Nurse Initiated Antiretroviral Therapy (NIMART). 
The first part of this literature review will analyse the epidemiology of HIV in South 
Africa. This will be followed by the second part which will focus on how NIMART 
was established and how it was going to be implemented in Primary Health Care 
clinics, and also what impact NIMART is going to have on improving patient care 
of people living with HIV. 
The third part of this literature review will then focus on an overview of primary 
health care. This part will review the literature on the role of nurses in primary 
health care and in the provision of Antiretroviral Therapy. 
 The fourth part of this literature review will focus on the decentralisation of 
Antiretroviral Therapy and task shifting of antiretroviral initiation from being doctor-
led to nurse driven. The review will also focus on the challenges nurses have been 
facing with the task shifting. 
The fifth part of this literature review will discuss HIV counselling and testing 
(HCT) and provider initiated counselling and testing (PICT). This is followed by the 
sixth part which focuses on Prevention of Mother-to-Child Transmission of Human 
Immunodeficiency Virus (PMTCT). 
The seventh section of this literature review focuses on the NIMART training, 
followed by the clinical mentorship of the NIMART trained nurses. Lastly, the 





2.2. THE EPIDEMIOLOGY OF HIV IN SOUTH AFRICA 
South Africa has the highest number of people living with HIV in the world. Despite 
the availability of voluntary counselling and testing (VCT) services since 2000, 
many South Africans have never tested for HIV and the uptake of voluntary 
counselling and testing (VCT) has been suboptimal. HIV-infected patients who 
consult their family practitioners are still being missed as opportunities to test and 
put on care (Makhunga-Ramfolo, Chidarkikire, Farirai and Matji, 2011). In a mid-
term review of the National Strategic Plan 2007– 2011, the Human Sciences 
Research Council (HSRC) reported that the HIV epidemic in South Africa 
appeared to have stabilised, although a significant number of South Africans did 
not know their HIV status and testing was still primarily client initiated(World 
Health Organization, 2007). 
SANAC reported in 2010 that in recent years there had been important changes in 
the management of HIV and TB, provided by the government of South Africa 
(SANAC, 201O). In 2007 the Deputy President had taken steps to revitalise 
SANAC, including the review of its terms of reference and membership. A 
revamped multi-sectoral National Strategic Plan on AIDS and STIs (2007–2011), 
the NSP, was developed with all key stakeholders in government, civil society and 
the private sector. It had ambitious targets of reaching 80% of those who needed 
to be on ARVs by 2011and a 50% reduction in new infections by the same time. 
2.3. NIMART 
Antiretroviral Therapy and the management of HIV-positive patients was initially a 
doctor-led program. However, as the incidence increased (that is, the amount of 
newly diagnosed HIV infections every year), the number of patients that needed to 
be initiated on antiretroviral drugs also increased. As a result, doctors became 
overloaded and could no longer cope with the work load. Hence, NIMART was 
invented to relieve the doctors’ workload and of course to increase access to ART. 
The UNAIDS report of 2008, pointed out that in recent years there had been a 
tremendous global push to enhance HIV/AIDS prevention and treatment efforts, 
with a specific focus on increasing the access of low income countries to Anti-
Retroviral Therapies (ART) (UNAIDS, 2008). As a result, generic ART has 
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become cheaper and more widely available across Sub-Saharan Africa, but huge 
inequality still exist in access to services, with only 30% of those needing 
treatment currently able to obtain it. 
Brennan, Long, Maskew, Sanne, Jaffray, Macphail and Fox (2011) state that the 
utilisation of nurse managed Primary Health Care clinics (PHCs) for the treatment 
continuation of stable patients could reduce the load of HIV-positive patients that 
need to be seen at the hospitals and only the specialised doctor-managed ART 
patients would remain at the hospitals. According to Smith, Diergaardt, Fourie, 
Matshikwe and Letsoalo (2011), there was evidence for successful non-physician 
provided ART in Africa and particularly in South Africa, with equivalent ART 
treatment outcomes in terms of viral load suppression, mortality and retention in 
care, being reported. Hence, nurse initiation and management of patients on ART 
(NIMART) was identified as a key strategy to obtain this goal. Colvin, Fairall, 
Lewin, Georgen, Zwarenstew, Bachmann, Liebel and Bateman (2010), also stated 
that field reports from programs that had utilised cadres other than physicians to 
distribute ART in remote areas of South Africa, were more abundant and reported 
equally positive results for both ART outcomes and improved access. 
Due to the long waiting list of patients awaiting ART initiation and the inadequate 
number of doctors available, some patients died prematurely while waiting to be 
initiated on ARV’s. Georgeu, Colvin, Lewyn, Bachmann, Uebel, Zwarenstein, 
Draper and Bateman (2010) stated that PALSA (Practical Approach to Lung 
Health in South Africa) PLUS had been well accepted and successful in the Free 
State. However, health managers were still worried about the constantly high 
mortality of ART-eligible patients awaiting treatment initiation, and were worried 
about the persistent shortage of physicians available to supply and initiate ART. 
According to Cameron, Gerber, Mbatha, Mtyabule and Swart (2012), further 
motivation to rapidly improve access was evidence showing that more than 80% of 
deaths during the first year after diagnosis of HIV infection occurred before these 
patients could be started on ART. Therefore, nurse initiation and maintenance of 
Antiretroviral Therapy (NIMART) improves access, is cost effective, is not inferior 
to doctor-managed ART, and achieves similar outcomes of viral suppression, 
adherence, toxicity and death (Cameron et al. 2012). 
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Nurses in the Free State in 2010 accepted the extensive raise in workload with 
NIMART since they believed they were well equipped and supported, and had 
responsibility to save the lives of patients who would have died before being 
initiated on treatment (Colvin et al., 2010). 
Georgeu et al. (2012) pointed out that NIMART appears to be possible and 
suitable in the primary health care system in South Africa. NIMART was generally 
well accepted by nurses. Furthermore, nurses were keen and excited to be offered 
an opportunity to be hands-on in supplying treatment that saves lives. Although 
the Lesotho Ministry of Health and Social Welfare stated that Lesotho had 
permitted nurse initiation since 2006 and it had been incorporated formally into the 
Lesotho National Treatment Guidelines, many countries in Southern Africa have 
been reluctant to endorse nurse initiation of ART despite the fact that it is 
recommended by the World Health Organization. 
When the ambassador Eric Goosby delivered a key lesson from a decade of 
action on Global AIDS, and discussed the way forward, at the International AIDS 
Conference in 2012, he mentioned in his speech that in the United States having 
access to this treatment has transformed HIV/AIDS into a long chronic condition, 
cared for largely in an outpatient setting. It had saved many, many lives, but this 
access to treatment was not universal. “About thirteen years ago, I turned my 
attention to the global pandemic, and I will never forget what those early years 
showed us. AIDS was wiping out a generation and reversing health gains in Africa 
(International AIDS Conference, 2012).” 
In conclusion, the good news is that a study conducted by Georgeu et al. (2012) 
indicated that NIMART was highly acceptable among nurses, doctors and 
patients. It also revealed that managers and nurses expressed confidence in their 




2.4. PRIMARY HEALTH CARE (PHC) AND ROLE OF NURSES IN PHC 
2.4.1. PRIMARY HEALTH CARE 
Wentzel (2008) defines Primary Health Care (PHC) as the cornerstone of health 
services in South Africa as this is a patient’s first level of contact with a health 
service. The policy of the National Health System in South Africa also states that 
Primary Health Care services form the basis of health service delivery in South 
Africa. These services are rendered by primary health care clinics, which have to 
implement the PHC package. Wentzel (2008) further mentions that PHC was the 
key element in the South African government’s plan to transform health services in 
South Africa to ensure availability of a comprehensive and integrated package of 
essential health services for the entire population and in providing a solid 
foundation for a single unified health system. PHC would be the driving force in 
promoting equity in health care. 
Moreover, Wentzel (2008) points out that PHC services should address the 
leading cause of mortality and morbidity in the country, so these services had to 
be accessible to the broader community throughout South Africa. Professional 
nurses in the clinics do referrals to the next level of services, where necessary. 
The vehicle for the delivery of the PHC package is the district health system 
(DHS). The DHS comprises of both fixed and mobile clinics, Community Health 
Centres (CHC’s) and district hospitals (where access to clinics and CHC’s is 
limited). All provinces indicated the need to link the PHC package more clearly 
with the district hospital (Wentzel, 2008). 
The World Health Organization supports the role of PHC and community–led care 
in the delivery of Antiretroviral Therapy in the remote areas with limited resources 
(World Health Organization, 2006). Bedelu, Ford, Hilderbrand and Reuter (2007) 
state that the outcome data in a Lusikisiki survey illustrate that ART can be 
initiated at the primary health care level with very acceptable outcomes, and also 
that ART initiation at primary health care enables quicker enrolment than does 
initiation done only at the hospital.  
However, there were no new additional nurses to PHC clinics with the introduction 
of NIMART and the nurses became overwhelmed. Wentzel (2008) pointed out that 
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more programs were still being introduced to primary health care facilities, 
irrespective of inadequate staff establishment which was causing stress and 
burnout of PHC nurses. 
2.4.2. ROLE OF NURSES IN PRIMARY HEALTH CARE 
Nurses are the backbone of health care systems across the world. Nurses have 
always been in the forefront of patient care, providing holistic healthcare to 
patients from clinic level to bed-side. A lack of doctors and the traditional role 
played by the nurses, means that they will continue to have a central role to play 
in not only ensuring universal access to ART for patients in need, but also in the 
primary prevention and the timely identification of HIV infection (Smith et al.,                 
2011). 
The Standard Treatment Guidelines and Essential Medicines List (2014), was 
implemented in primary health care clinics and professional nurses were allowed 
to issue Level 1 and 2 medicines, depending on the grading of the clinic. Level 1 
medicines can be prescribed by a professional nurse according to the Standard 
Treatment Guidelines, and Level 2 medicines can only be prescribed by a doctor. 
The PHC approach requires professional nurses to have comprehensive skills in 
order to render these services in PHC clinics. South Africa has various categories 
of training for professional nurses, regulated by the Nursing Act, 50 of 1978, as 
amended, now replaced by the Nursing Act, 33 of 2005, resulting in different skill 
levels (Wentzel, 2008). 
Smith et al. (2011) stated that the health system in South Africa is reliant on nurse-
led services to deal with the burden of HIV/AIDS epidemic facing South Africa. 
According to Cameron et al. (2012), Dr. K. Chetty, the Acting Director–General of 
Health, authorised professional nurses who had undergone NIMART training and 
were mentored to initiate ART on HIV-infected patients as from 1 April 2010. 
Dohrn, Nzama and Murrman (2009) pointed out that the urgent need for nurses to 
engage in greater clinical responsibilities in the care of patients with HIV/AIDS has 
encouraged the practice of task shifting in South Africa. According to Brennan et 
al. (2011), nurse-managed care has also been estimated to be cost effective. 
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2.5. DECENTRALISATION OF ANTIRETROVIRAL THERAPY AND TASK 
SHIFTING 
2.5.1. DECENTRALISATION OF ANTIRETROVIRAL THERAPY 
The increase in the number of patients eligible to access care and the World 
Health Organization recommendation to treat patients at higher CD4 cell counts 
has put pressure on health systems and forced governments to seek new models 
of treatment delivery. Models of care adapted from industrialised countries 
typically have a large doctor–patient ratio with increasing demand, a shortage of 
trained medical staff and limited finances. To attend to these concerns, a proposal 
of decentralising care to smaller health facilities along with task shifting care from 
doctors to clinical officers, nurses and community health workers was 
recommended (Brennan, 2011). Bedelu et al. (2007) suggest that integration and 
task shifting assisted the work load among the staff, whereas decentralisation 
assisted to distribute the hospital’s work load among different clinics. 
Decentralisation involves the implementation of comprehensive HIV counselling 
and testing, care and treatment services at the first levels of health care (Smith et 
al., 2011). To implement decentralisation, the following must be in place: policies 
allowing non-physicians to initiate and monitor treatment and the development of a 
healthy workforce comfortable with and skilled in initiating and monitoring 
treatment, including treatment services for pregnant woman, infants and children. 
Colvin et al. (2010) suggest that decentralising ART to all clinics throughout the 
country would necessitate a major reshuffle of workloads and relationships among 
various levels of care. Decentralisation of ART to PHC clinics allows increased 
access, equity and better support of adherence to ART.  
Health care workers are the main role players to scaling up Antiretroviral Therapy 
(ART), particularly in rural areas, like in Lusikisiki. Medecins Sans Frontiers has 
been supporting a program to deliver HIV services through decentralisation to 
PHC clinics, task shifting and community support. This approach has allowed for a 
rapid scale up of treatment with satisfactory outcomes, and the delivery of HIV 
services in Lusikisiki was achieved (Bedelu et al., 2007). 
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Brennan et al. (2011) stated that South Africa’s National Department of Health 
commenced decentralising the care of patients that were stable on ART or who 
were initiated and managed by doctors at hospitals, to clinics using nurse-
managed care. Furthermore, several studies have supported the decentralisation 
of HIV treatment and have also proved that retention in care and clinical outcomes 
were improved. 
2.5.2. TASK SHIFTING 
Georgeu et al. (2012) claimed that the Antiretroviral Therapy (ART) programme for 
HIV/AIDS in Southern Africa was increasing in the public sector and this has 
created additional workload, organisational challenges and great concerns about 
the ongoing shortage of human resources for health. While most programs in 
South Africa have used a model of physician-initiated and managed ART, yet 
there are insufficient physicians in the public sector.  
In South Africa there are 69 doctors and 388 nurses per 100 000 population. 
Therefore, task shifting for initiating and maintaining ART from doctors to nurses is 
a reasonable solution to meet the need of increased access (Cameron et al., 
2012). 
Georgeu et al. (2012) suggested that due to the insufficient numbers of personnel 
of physicians mainly in low and middle – income countries with extensive ART 
programs, there has been an agreement that some ART would be supplied by 
other non-physicians in order to achieve ART coverage. Task shifting from 
physicians to nurses has been proposed as one response to the challenge of 
large scale, sustainable, and effective ART programs in resource constrained 
contexts. 
Furthermore, task shifting of roles and responsibilities for HIV care and treatment 
in this context can take a number of forms depending on how services are 
structured. In the context of HIV/AIDS care, the term ‘Nurse-Initiation and 
Management of ART – NIMART’ is proposed. In its fullest sense, NIMART 
involves nurse–initiation of patients into ART, re-prescription for patients stable on 
ART, and appropriate referral to physicians as needed (Georgeu et al. 2012). As 
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nursing responsibilities with regard to HIV care have risen, tasks have been 
shifted to other categories of staff, necessitating the reshuffling of health teams 
and the formation of new abilities at numerous levels. Task shifting has been 
recognised by the World Health Organization as an essential and justifiable means 
to meet the critical health needs which are the consequences of the HIV pandemic 
(Dohrn et al. 2009).  
NIMART is a comprehensive intervention for health systems that aimed to improve 
access to ART by moving assessment and treatment to primary health care clinics 
closer to the patient’s homes. The intervention developed clinical responsibility for 
ART from physicians to nurses for stable patients (task shifting), and other aspects 
of HIV and ART care were integrated into primary health care services (Mann and 
Lin, 2012). 
Colvin et al. (2010) argue that even though task shifting is commonly approved as 
an answer to expanding ART access, evidence shows that non-physician care in 
providing ART in Africa is restricted. Moreover, in these studies non-physician 
care is limited to the monitoring of patients who are already on treatment, with 
initiation usually being done by study physicians under these conditions. All 
studies reported equivalent ART treatment outcomes, including viral load 
suppression, mortality and retention in care. Unlike South Africa, Cohen et al. 
(2009) state that the Lesotho health authorities promoted task shifting to enable 
every category of nurses to have diagnosing, prescribing and dispensing authority. 
This model was gladly accepted by the Ministry of Health and Social Welfare for 
replication throughout the country. 
2.6. HIV COUNSELLING AND TESTING (HCT) AND PROVIDER INITIATED 
COUNSELLING AND TESTING (PICT) 
2.6.1. BACKGROUND 
The South African National AIDS Council (SANAC) (2010) states that with the 
introduction of new guidelines in February 2010, South Africa’s policy on voluntary 
counselling and testing was expanded to incorporate a number of new 
components. These components include a revision of counselling protocols as 
well as a shift for HIV Counselling and Testing (HCT) to be offered by health 
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providers during patients’ consultation to any health facility for any ailment. 
SANAC (2010) points out that provider-initiated HIV counselling and testing 
remains voluntary but the health care worker has a responsibility to give the 
patient information about the importance of knowing one’s HIV status and of 
testing regularly for HIV as part of a normal health seeking behaviour. The shift 
towards provider-initiated HCT comes as one of the measures derived from the 
10-point plan of the National Department of Health – particularly the intention of 
point 1: ‘Providing Strategic Leadership for better health outcomes’ and of point 7: 
‘Accelerating implementation of the HIV & AIDS and Sexually Transmitted 
Infections National Strategic Plan 2007–11’ (SANAC, 2010). 
Makhunga-Ramfolo et al. (2011) declare that in 2007 WHO made 
recommendations to launch provider-initiated counselling and testing (PICT) on 
top of client-initiated counselling and testing also known as voluntary counselling 
and testing (VCT), as an efficient public health intervention to enhance access to 
HIV counselling and testing (HCT) and to decrease missed opportunities for 
testing. Makhunga-Ramfolo et al. (2011) further state that the recent HCT policy 
guidelines from the National Department of Health (2010) put emphasis on the 
need to complement VCT through the implementation of PICT by all health care 
providers in both the public and private sectors. This strategy aims to assist health 
care providers to expand access to HCT for their clients, and thus the burden of 
disease in communities will ultimately be reduced. 
2.6.2. HIV COUNSELLING AND TESTING (HCT) 
The Department of Health (2010) mentions that the National HCT Program aimed 
to provide universal access to good quality, effective HIV counselling and testing 
and become an effective referral system to all South African citizens. The aims of 
the HIV counselling and testing program are to: 
 Create an enabling environment that promotes universal access to a safe, 
effective and good quality HCT service; 
 Encourage individuals, couples, families and communities to test for HIV in 
the interests of their own health; 
 Promote support for positive living, healthy lifestyles and good nutrition; 
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 Encourage and support the voluntary disclosure of HIV status and to 
minimise stigma; 
 Facilitate and promote the integration of HCT with family planning (FP), 
tuberculosis (TB), sexually transmitted infections (STIs), and other 
communicable and non-communicable diseases; and 
 Integrate affordable, feasible, accessible, safe and sustainable HCT 
services into the health system. 
 
Furthermore, the DOH (2010) stated that the government’s ‘new’ HIV Counselling 
and Testing (HCT) campaign had set a target to test a total of 15 million people 
who had been at risk throughout South Africa by the end of June 2011. Expanding 
access to HIV counselling and testing is seen as an essential gateway to HIV 
prevention as well as providing appropriate treatment and care for people who are 
already infected. With the introduction of new guidelines in February 2010, the 
government’s policy on voluntary counselling and testing (VCT) has been 
expanded to include provider-initiated HCT. Previously healthcare workers 
recommended testing only if HIV disease was suspected. Now regular HIV testing, 
while still voluntary, was to be routinely recommended to everyone as an 
important part of normal health-seeking behaviour. Objectives of the campaign 
were as follows: 
1. To mobilise people to know their status. 
2. To provide key prevention messaging to encourage healthy lifestyle 
practices irrespective of HIV status. 
3. To increase incidence of health-seeking behaviour. 
4. To increase the access to treatment, care and support (DOH, 2010). 
Makhunga-Ramfolo et al. (2011) pointed out that in clinical settings lots of patients 
were not offered HIV counselling and testing (HCT) and become missed 
opportunities for HIV diagnosis.  
SANAC (2010) considered HCT to be a starting point of HIV prevention, by 
knowing one’s status and knowing what to do thereafter and by facilitating 
initiation to antiretroviral treatment. HCT incorporates prevention and treatment, 
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which both strengthen the National Strategic Plan for HIV and AIDS and STIs, 
2007–2011 (NSP). Most often HCT is significant, determined and action-oriented, 
which makes extensive social mobilisation feasible. It is hard to measure the 
effectiveness of HCT in primary prevention for HIV-negative patients. However, 
various supporting studies revealed that the effectiveness of HCT in secondary 
prevention for HIV-positive patients is significant. Studies have publicised the 
evidence of behaviour change and reduced viral loads by treatment initiation. 
Unknown HCT status also gives a restricted picture of who tested and who did not. 
These assist in discovering which populations were most-at-risk that were not 
reached. 
The National Strategic Plan for HIV and AIDS and STIs, 2007–2011 (NSP) was an 
intensive and coordinated response to the epidemic in South Africa (DOH, 2010). 
The NSP had two primary goals which were to reduce the incidence of new HIV 
infections in South Africa by half, and to ensure that at least 80% of those who 
were already HIV-positive had access to treatment by 2011.The common factor for 
both these goals was knowledge of HIV status. Specifically, key strategies in the 
NSP were to increase access to and uptake of voluntary counselling and testing 
(VCT), and to increase the geographic coverage of VCT services in medical and 
non-medical settings by 2011. In addition, the Plan sought to increase the 
proportion of people between the ages of 15 and49 years who accessed VCT 
services from 25% to 70%. 
Furthermore, the DOH in 2010 stated that HCT had turned out to be progressively 
more accessible in South Africa in previous years (DOH, 2010). More than 4500 
public health facilities were routinely offering HIV testing and client-initiated 
counselling and testing. With the escalating accessibility of HCT in numerous 
public health facilities in South Africa, the uptake of counselling and testing had 
been increasing as well. The ratio of people who had tested for HIV and knew 
their status had improved from 21% in 2002, to 30% in 2005, and to 50% in 2008 
(Shisana and Simbayi, 2012). However, Kalichman and Simbayi (2003) stated that 
in 2002, out of five South Africans who knew about the services, only one had 
actually used them. 
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2.6.3. PROVIDER-INITIATED COUNSELLING AND TESTING (PICT) 
Provider-initiated counselling and testing (PICT) was launched to make sure that 
HCT turns out to be the standard of care in all consultations with health providers. 
According to Makhunga-Ramfolo et al. (2011), PICT encourages general access 
to prevention, care and treatment services for all clients by maximising the use 
and acceptance of HCT services. With PICT the health care provider regularly 
suggests and recommends an HIV test to all clients, regardless of the medical 
diagnosis. The core objectives are to incorporate HIV testing into routine medical 
care, and in so doing, facilitating early diagnosis. Furthermore, Makhunga-
Ramfolo et al. (2011), point out that by implementing PICT, family practitioners 
would not only discover the client’s HIV status, permitting for proper clinical 
decisions to be made, but would also allow all clients to be aware of their status. 
Early diagnosis improves health outcomes of those who are HIV-positive, at the 
same time making sure that they are supplied with information to decrease 
transmission. 
The DOH (2010), refers to PICT as HIV counselling and testing which is initiated 
and recommended by health care providers to all clients attending health care 
facilities as a standard component of medical care. PICT and other options of 
testing should be offered at all points of care including trauma, casualty and 
specialist clinics. PICT is also recommended in all health services dealing with 
domestic or gender–based violence, child abuse and sexual violence. In addition, 
the DOH (2010) mentioned that PICT aimed at identifying early high risk clients for 
whom there may be a strong likelihood of HIV infection, either because of their 
symptoms, or because of high risk sexual behaviour, or in transmission areas. 
Makhunga-Ramfolo et al. (2011) further stated that the accessibility of HIV rapid 
tests and same-day results has increased access to accurate, trustworthy and 
cost effective diagnoses. HIV rapid tests enable medical practitioners to test their 
clients and give results within a short space of time. The relationship between 
medical practitioners and their patients puts them in a better state to give patient-
centred care, allowing for better decisions to be made. For patients consulting 
medical practitioners, PICT is a vital and efficient model that forms part of the 
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bigger prevention approach and acts as the door-way for accessing care, support 
and treatment services (Makhunga-Ramfolo et al., 2011). 
2.6.4. BENEFITS OF PICT 
Knowing the client’s HIV status can have advantages for the person concerned, 
the provider and the community. For HIV-negative people, knowing their status 
allows them to protect themselves from getting infected with HIV. It empowers 
them with necessary information on how to stay negative by assessing their own 
behaviour and offering solutions for behaviour change. For HIV-positive people, 
knowing their status ensures that they can be supplied with the suitable treatment, 
care and support services and helps them in living positively. Couples who know 
their HIV status are empowered to make safe choices with regards to sexual 
behaviour, e.g. condom use in discordant couples, practising a positive living 
approach, and accessing treatment for the prevention of mother-to-child 
transmission of HIV (Makhunga-Ramfolo et al., 2011). 
Furthermore, Makhunga-Ramfolo et al. (2011) point out that PICT allowed medical 
practitioners to treat their clients properly by prioritising those who required 
treatment and/or wellness programmes early on. This assisted health care 
providers to enhance the quality of medical care provided to their clients and to 
decrease morbidity and mortality. PICT helps in decreasing the stigma in the 
community by making HIV testing the norm. It resulted in the increasing of care 
and support services to deal with the demand for services. 
2.6.5. PRINCIPLES OF PICT 
PICT does not mean that people are forced to test, nor does it consist of 
compulsory or mandatory testing. There are three principles that should guide 
medical practitioners when applying PICT, which are: consent, counselling and 
confidentiality, also known as the three C’s. Improper use of PICT reduces trust in 
health care providers and can result in poor adherence to treatment and 
insufficient uptake of referrals (Makhunga-Ramfolo et al., 2011). 
The DOH (2010), states that PICT is initiated by the health-care provider or worker 
to support the uptake of HIV testing. The patient’s right to autonomy and dignity 
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should always be taken into consideration when HCT is being offered, while 
recognising the obligation of health-care providers to protect the right to life and 
access to health services. Furthermore, pre-test and post-test counselling should 
always form a part of PICT and the client should give an informed consent for 
testing in the language that he / she understands. 
(a) INFORMED CONSENT 
Medical practitioners should only perform HIV testing when the client or his or her 
parent or legal guardian has given informed consent. The client must be provided 
with information in his or her language. One must also consider disability and the 
level of literacy of the client when providing information. The client must also 
understand what the test consists of and its consequences. Furthermore, the client 
should understand the rationale of the exchange of information as being in the 
best interest of his or her own health, that of the partner, and the foetus (if the 




Makhunga-Ramfolo et al. (2011) declare that all HIV testing must follow the 
individual pre-test counselling. PICT does not need a lengthy counselling session, 
but the medical practitioner should be guided by the client’s knowledge and 
requirements. The following are some of the key points that should be covered 
during the pre-test counselling in adults: 
 Assessing the client’s understanding of information provided and reinforcing 
messages and concepts. 
 Assisting the client to determine and assess their risk based on the 
information provided. 
 Assessing the client’s readiness for testing and possible results. 
 Obtaining informed consent. 





All clients who are offered HCT and agree to a test should also get post–test 
counselling, regardless of HIV results. The content of post-test counselling will 
depend on the HIV test results (Makhunga-Ramfolo et al., 2011).  
(c) TESTING 
It is very simple to do the HIV rapid test, with good training. Results are available 
within 10 – 15 minutes during consultation with the client and are as reliable and 
accurate as enzyme immunoassays. A prescribed quality assurance programme 
should be followed by all persons performing HIV rapid testing in order to ensure 
that results are accurate and reliable. The prescribed national HIV testing 
algorithm should be used when performing HIV testing using both a screening and 
a confirmatory test (Makhunga-Ramfolo et al., 2011).The differences between 
HCT / VCT and PICT are outlined in Table 1 below. 
Table 1. Differences between PICT and HCT / VCT (Makhunga-Ramfolo et al., 
2011) 
PICT HCT / VCT 
Individual is seeking medical care and 
HCT is recommended and performed by 
medical practitioner as part of the 
consultation 
Individual chooses to seek HCT 
Services provided are confidential and 
documented in medical record to ensure 
continuity of care 
Anonymous or confidential services 
may be offered 
Primary focus is on identifying HIV-
infected people and linking them with 
prevention, care and treatment services 
Primary focus is on preventing HIV 
acquisition through risk assessment, 
risk reduction and testing 
Verbal consent is required and should be 
documented in the patient record 
Written consent or thumb print for 
illiterate clients is required 
First user of the test result is the health 
care worker to make a correct diagnosis 
and provide appropriate treatment 
First user of the best result is the 
client, who uses the information to 
make personal life decisions 
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2.6.6. CONFIDENTIALITY AND DISCLOSURE 
Makhunga-Ramfolo et al. (2011) argue that although confidentiality needs to be 
maintained in HCT, clients should be persuaded to disclose their results to their 
sexual partners. Health care workers should talk about the issue of shared 
confidentiality with the client. That is, health care workers who are directly involved 
with care of a patient may have access to his or her results. Medical practitioners 
can also suggest assisting clients to disclose their HIV status to their partners. 
Makhunga-Ramfolo et al. (2011) further state that medical practitioners must be 
warned against disclosing HIV status to third parties without either the client’s 
written consent or a court order. Medical practitioners should consult with senior 
consultants for a second opinion if not sure about patient management. 
The view of South African Nursing Council (2014) is that the ethical problems with 
the nursing of HIV/AIDS patients arise mainly from faulty perceptions. 
These patients have the right to: 
 confidentiality; 
 non-judgemental, effective nursing according to personal needs; 
 empathy for the social dilemma of AIDS and HIV-positive patients; 
 expert accompaniment for themselves, their families and communities, in 
order to continue a normal, responsible life; and 
 protection and life, in the case of the unborn child. 
The South African Nursing Council condemns: 
 Discrimination against HIV/AIDS-infected patients; and 
 Violation of confidentiality. 
2.6.7. HIV COUNSELLING PROCESS 
The diagram below illustrates the counselling process for PICT and HCT that must 
be conducted in all public health facilities. It should be conducted in the language 
that the client prefers and understands (DOH, 2010). There are different ways at 
which pre-test information sharing sessions may be conducted, either with groups, 
couples or individuals. Thereafter a brief individual session that address individual 




















































2.6.8. HIV TESTING 
HIV testing must be ethical, based on human rights, conducted within a supportive 
environment and be performed where there is adequate health care infrastructure 
(DOH, 2010). A trained healthcare professional (registered nurse, doctor, dentist 
and oral therapist or oral hygienist) is responsible for administering the HIV test in 
terms of current legislation (Human Tissue Act No. 65 of 1983 section 23). 
 
The task shifting / sharing policy was finalised and being implemented for trained 
HIV counsellors. This policy resulted in the following changes: 
 A trained health care worker, enrolled nurse, community health worker or 
counsellor may then be authorised, in terms of the task shifting policy, to 
administer the HIV test. 
 All healthcare workers who administer the test will receive required training 
to ensure adherence to the standard operating procedures, utilisation of 
approved testing kits, and quality assurance of HIV testing. 
 HIV testing conducted by a healthcare worker, should be under the 
supervision of a healthcare professional (i.e. registered nurse, doctor, 
dentist, oral therapist or oral hygienist). 
 A trained healthcare worker / counsellor will be responsible for performing 
the test, interpreting and confirming the results of the test, as well as 
informing the client of the results. 
 A trained registered nurse will supervise the quality assurance processes 
for HIV testing (DOH, 2010). 
 
2.6.9. FREQUENCY OFTESTING 
The DOH (2010) states that health facilities are also intended for including a 
culture of HIV testing for individuals. A patient’s exposure needs to be considered 
to determine the correct frequency of repeat HIV testing. Patients who are sexually 
active must be motivated to test at least annually and this should be encouraged 
as part of the culture of proactive self-care that all health providers must adopt. 
Nevertheless, patients who are at high risk of exposure can have repeat testing 




2.6.10. TESTING ALGORITHM 
The HIV testing algorithm that is approved in SA is serial testing. This means that 
a screening test is performed first, and then a confirmatory test is performed latter 
depending on the result of the screening test. If the screening test is positive a 
confirmatory test is performed. If the results are discordant, then whole blood is 
taken and sent to the laboratory for ELISA test. Professional nurses were 
authorised to perform HIV rapid testing and lay counsellors were not supported by 
legislation to perform the test back then (SANAC, 2010). According to the DOH 
(2010), the HIV testing algorithm that must be used for all HIV testing is the serial 



























2.7.1. PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV 
(PMTCT) PROGRAMME IN SOUTH AFRICA 
The Prevention of Mother-to-Child Transmission of Human Immunodeficiency 
Virus is abbreviated as PMTCT and was introduced in 2001 in South Africa in the 
Province of KwaZulu-Natal at King Edward Regional Hospital which is situated in 
Durban. The aim of this programme was to reduce the number of HIV-infected 
babies born to HIV-positive mothers (Ngidi, 2011). 
Mother-to-Child Transmission of HIV can occur through HIV-positive women 
passing on infection to their unborn babies (vertical transmission), or through 
breastfeeding, according to Ngidi (2011). South Africa was experiencing an 
overwhelming HIV/AIDS pandemic, it was estimated that maternal mortality in 
KwaZulu-Natal was 192.3 per 100, 000 live births due to HIV epidemic (Ngidi, 
2011). 
The Prevention of Mother-to-Child Transmission of Human Immunodeficiency 
Virus (PMTCT), was aiming amongst other things, at reducing the number of 
infected babies born to HIV-positive mothers (Ngidi, 2011). PMTCT involves 
methods that reduce HIV transmission during pregnancy, labour and delivery, and 
through breastfeeding. 
Initially, the programme had only one drug, this being the single dose Nevirapine 
(sd NVP), which was considered by the World Health Organization (WHO) as the 
minimum standard of care for pregnant mothers living with HIV, and which was 
recommended by the WHO. This was to be taken by the mother when in active 
labour, and given to the infants within 72 hours of their delivery. The current 
transmission rate with sd NVP is 21%, high above the expected 12%, which was 
the target for single dose Nevirapine in the PMTCT Program (Ngidi, 2011). 
Ngidi (2011) states the implementation of the program in 2001 did not transpire 
without controversy. The Treatment Action Campaign (the activists in support of 
the provision of antiretroviral treatment) was pushing the National Department of 
Health to commence the PMTCT Programme. The National Health Department 
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started by piloting the PMTCT programme consisting of monotherapy (sd NVP). 
The Treatment Action Campaign (TAC) felt that the pilot studies in the 18 sites, 
done by the NDOH, should be converted to a roll-out, not only to the 18 sites, but 
to all state facilities that could dispense it.  
Following a court order, the Department of Health had no choice but to implement 
the program. The TAC won the court order in 2003; therefore the sd NVP PMTCT 
was spread across all the state facilities, not only the piloted sites. The Minister of 
Health at the time was Minister Manto Tshabalala-Msimang. She was publicly 
criticised for delaying revising the sd NVP to dual therapy, which according to the 
TAC spokesperson (Nathan Geffen in 2003), was a scientifically proven method of 
reducing Mother-to-Child Transmission. On 25 January 2008, the DOH announced 
a new national protocol for the PMTCT, namely the introduction to Dual 
Antiretroviral prophylaxis, which consisted of sd NVP plus Zidovudine (AZT). 
Though the TAC welcomed the revised program, they felt it should have included 
Lamivudine (3TC), as recommended by the World Health Organization for the 
PMTCT of HIV, and not just the abovementioned two drugs. For the TAC, another 
shortfall of the NDOH was that pregnant mothers were to be initiated on 
Antiretroviral Therapy once their CD4 was 200 cells/mm3 or below. The TAC felt 
this was outside the current international best practice, because the WHO 
recommended a CD4 count of 350 cells/mm3 and below (Ngidi, 2011). 
Ngidi (2011) stated that according to scientific evidence, there was an advantage 
to be gained in initiating ART at a CD4 count of350 cells/mm3 and not 200 
cells/mm3.The United States and European treatment guidelines recommend that 
all patients including pregnant mothers start Anti-HIV treatment at a CD4 count of 
350 cells/mm3. This was not the case in South Africa at the time of Ngidi’s study. 
In 2007 alone, 330 000 HIV-positive pregnant women gave birth in South Africa, 
with the estimate that 70 000 of their infants were born HIV-positive. WHO 
recommended that the full implementation of the revised protocol would have 
reduced the numbers significantly. 
Resistance has developed with the use of single dose Nevirapine for the PMTCT 
programs, which can compromise the success of the subsequent treatment of 
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mother and child with ARV. The study by Ngidi (2011) on the prevalence of 
resistance to NVP in mothers and children after single dose NVP exposure to 
prevent vertical transmission of HIV-1, revealed that there was a high burden of 
viral resistance in both women and children. The single dose NVP is considered a 
minimum standard of care for women living with HIV who are pregnant. The dual 
therapy revised new PMTCT programme, which consists of Zidovudine (AZT) and 
Nevirapine (NVP), which is the recommendation by the World Health 
Organization, is considered more effective than the single dose NVP. Initially the 
WHO had recommended the single dose NVP, but new evidence became 
available which supported the effectiveness of the Antiretroviral Treatment (ART) 
in the prevention of Mother-to-Child Transmission (Ngidi, 2011). 
This was supported by a study done in Khayelitsha, Cape Town, South Africa, 
which aimed at estimating the efficacy of the PMTCT program in Khayelitsha, and 
at providing details of the antiretroviral regimens received by mothers and infants. 
The results revealed that the majority of pregnant women in Khayelitsha accepted 
HIV testing during pregnancy, and were prepared to join the program. This 
acceptance of testing was the key to the effectiveness of the PMTCT program 
(Ngidi, 2011). According to Ngidi (2011), in developing countries like South Africa, 
on average, less than 10% of women received even the most basic PMTCT 
services, and, therefore, access to the PMTCT services remained low. 
2.7.2. HIV COUNSELLING AND TESTING OF PREGNANT WOMAN FOR THE 
PMTCT PROGRAMME 
In order for the PMTCT programme to be successful, it is important that pregnant 
HIV-infected women are identified (DOH, 2010). All pregnant women must be 
screened for HIV routinely and be aligned with basic Antenatal Care (ANC), 
Rhesus factor, haemoglobin, and syphilis. HIV testing should be implemented 
during ANC as follows: 
 PICT (opt out approach) should be offered to all pregnant women and if 
they choose to opt out, a refusal or opt out form should be signed and this 
should be captured in their files. 
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 Women who decline HIV testing need to be counselled and convinced to do 
the test, by explaining the advantages of testing. 
HIV-NEGATIVE: Women who test HIV-negative should get post-test counselling 
on how to sustain their HIV-negative status and on risk reduction interventions, 
while they continue to receive routine antenatal care. Furthermore, they should be 
retested for HIV at or around 32 – 34 weeks to identify late seroconversion, and if 
they test positive, PMTCT prophylaxis should be immediately initiated. 
UNKNOWN STATUS: Unbooked women and women of unknown status 
presenting in labour must have HCT done in the latent phase of labour, and if 
possible in the first stage of labour. If they test positive for HIV, a PMTCT 
intervention should be offered and their babies must be given Post Exposure 
Prophylaxis (PEP). 
HIV-POSITIVE: All HIV-positive pregnant women should have the CD4 count 
recorded on the same day that HIV-positive status was diagnosed, and if possible 
at the first ANC visit, and should be classified as clinical stage according to WHO 
staging. These women should also: 
 Be screened for TB, as well as all basic ANC procedures. 
 Be initiated on ARV regimens prescribed by a registered health 
professional in line with the latest PMTCT guidelines, either PMTCT 
prophylaxis or highly active antiretroviral therapy (HAART). 
Women attending the postnatal care clinic at six weeks, whose status is unknown 
and who tested negative during pregnancy, may have acquired HIV infection 
recently and need to be offered a repeat HIV test to screen herself and her baby 
for HIV infection and exposure (DOH, 2010). 
2.8. NIMART TRAINING, FOLLOWED BY THE CLINICAL MENTORSHIP OF 
THE NIMART TRAINED NURSES 
2.8.1. NIMART TRAINING 
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Istre (2011) stated that NIMART Training started sincerely in March 2010. 
However, training only was proved insufficient to produce competent and 
confident nurses in initiating ART. Hence, the Clinical Mentorship component 
became extremely important. However, Cameron et al. (2012) mention that in 
October 2010, saturation NIMART training for nurses was rolled out in 7 
provinces. By the end of March 2011, 1736 nurses had attended at least one of 
the 39 NIMART Courses facilitated by the Foundation for Professional 
Development (FDP). Furthermore, Istre (2011) states that ARV therapy changes 
more frequently, which calls for nurses to be updated now and again of new 
developments in the treatment and care of HIV/AIDS. 
Department of Health (2010) states under the new guidelines that NIMART-trained 
nurses were allowed to administer ARVs, but some did not feel confident enough 
to implement their training without clinical support from a more experienced nurse 
or doctor. Hence, nurses who had received NIMART training required onsite 
supportive supervision in order to become competent and confident in their ability 
to provide high quality treatment for clients requiring ART. 
Georgeu et al. (2012) also stated that speeding up the rollout of ART in sub-
Saharan Africa has emphasised the necessity for capacity building at both the 
clinical and health system levels, and also for the integration of comprehensive 
HIV/AIDS care with primary healthcare. Hence, Istre (2011) suggested that nurses 
should first undergo a10-day theory training course and then go back to the facility 
to manage certain cases of HIV-positive patients who are on ART. A manual was 
then developed and a logbook to record the 54 clinical competencies or tasks. 
These have been of the utmost importance to clinicians nationwide as they form 
the basis for determining if a provider, irrespective of cadre, is clinically competent 
to manage and initiate patients on ART (Istre, 2011). 
Comprehensive in-service theoretical and practical training on the management of 
HIV-related conditions and ART was provided to nurses, in order to equip them 
with the skills to cope with these new responsibilities. This comprised of quarterly 
“out of service” trainings, taking one week each, which were clinical trainings 
adapted from the World Health Organization’s (WHO’s) Integrated Management of 
39 
 
Adolescent and Adult Illnesses (World Health Organization, 2004).According to 
Dohrn et al. (2009), the South African Nursing Council was taking into 
consideration a review of nursing curricula to approve new specialised degrees in 
HIV care and was also considering approving an amendment in nursing scope of 
practice to include NIMART. 
2.8.2. CLINICAL MENTORSHIP 
The Department of Health (2011) defines clinical mentorship as a system of 
practical training and consultation that fosters ongoing professional development 
of mentees to deliver sustainable high-quality clinical care. Clinical mentoring 
should be seen as part of the continued professional development required to 
create competent care providers. Following initial theoretical teaching, which 
conveys knowledge on a particular subject, the clinician responsible for providing 
quality care and treatment is mentored at the facility level to put into practice 
clinical standards (guidelines), to concentrate on knowledge, attitudes and 
behaviour, and thus to improve competency. 
In September 2011, Global Medic Force and the Foundation for Professional 
Development (FDP) deployed to South Africa a nurse with 25 years’ experience in 
HIV clinics in the UK for a 3 month volunteer mentorship in the Central Karoo town 
of Graaff-Reinet, Cacadu District, Eastern Cape. This mentorship assignment was 
to support primary care nurses trained in Nurse Initiation and Maintenance of 
Antiretroviral Therapy (NIMART). By the end of a 3 month mentorship period 
nurses were competent and had confidence to initiate ART.  
Nurses working in primary healthcare clinics throughout South Africa have shared 
the duty of initiating ART and subsequently patient management, due to the 
urgent need to expand ART access to 80% of eligible HIV-positive people. In 
addition to training, nurses have required regular support and mentoring to 
perform this task competently (Jones, Stander, van Zyl and Cameron, 2012). 
Muller (2012) pointed out that initially managing the ART program has been felt to 
be simply another burden and the nurse mentor has been seen as the instigator of 
this additional pressure, until nurses felt the benefit of her support.  
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Cameron et al. (2012) suggested that the spreading out of clinical mentorship was 
required immediately if the target of initiating1.2 million HIV-positive patients on 
ART by 2012, was to be reached. In response to this need, the National 
Department of Health has been working to introduce a comprehensive program for 
ART Clinical Mentoring throughout South Africa (Department of Health, 2010). 
National clinical mentorship guidelines were finalised in January 2011, at a time 
when 7492 nurses had undergone NIMART training nationally, with 23% (1745) 
initiating ART after training. The clinical mentorship guidelines were published to 
provide guidance for provinces, districts, and sub-district management teams to 
develop and integrate clinical mentoring within the district health system 
(Medecins Sans Frontiers, 2012). 
The DOH (2011) stipulated thatNIMART mentorship is guided by the national 
guidelines for Clinical Mentorship for Integrated Services. The NIMART 
mentorship is provided directly and indirectly through telephone access to 
mentors. Mentorship has become an essential element in ensuring equitable 
access to quality care and competent clinical providers. Figure 4 below shows the 
stages of mentorship. Clinical mentors must ensure that mentees examine and 
treat a broad range of patients, across the lifespan, from infants to older adults. 
The mentees must be deemed competent in all aspects of the speciality area in 
which they are being mentored. The mentee must provide care for adults and 
children in Pre-ART care, ART initiation, TB/HIV co-infection, HIV-infected 
pregnant women, etc., and must be in consultation with the mentor to assure all 
patient types are included in the logbook evaluation. Log books are used by the 
mentees to record 80 completed cases as laid down in the Clinical Mentorship 
Manual for Integrated Services. Log book and proof of competencies completed 
by the mentor form a Portfolio of Evidence (POE). The completed log books are 
kept by districts for record purposes and names are forwarded to provincial offices 
for certification. The certificate is issued and signed by the provincial Regional 
Training Centre (RTC) and co-signed by the mentor, district Training Coordinator 





Figure 4. Clinical Mentorship Framework NIMART Clinical Mentorship Model 
for Integrated Services. 
Pre-NIMART: PALSA Plus HIV course training on the use of South Africa’s 
approved algorithmic tool for diagnosis and treatment of common opportunistic 
infections; A1: NIMART training based on South African Ministry of Health 
guidelines; A2: Authorisation to initiate is granted based on three required criteria: 
completion of basic HIV course, PALSA Plus HIV training, and 40 hours of one-on-
one mentorship; B: Basic End Point is reached where the authorised nurse is 
conducting independent initiations; C:Advanced End Point is reached when skill 
level is expanded to include management of pediatric patients, virologic failure, 
and drug-resistant TB. 





This chapter analysed the epidemiology of HIV in South Africa. Then it focused on 
how NIMART was established and how it was going to be implemented in Primary 
Health Care clinics and what impact NIMART was going to have on improving 
patient care of people living with HIV. An overview of primary healthcare was also 
discussed as was the task of nurses in primary healthcare in the provision of 
antiretroviral therapy. This chapter also focused on the decentralisation of 
Antiretroviral Therapy and task shifting of antiretroviral initiation from being doctor-
led to now nurse driven, and also the challenges nurses have been facing with the 
task shifting. Differences between HIV Counselling and Testing (HCT) and 
Provider-Initiated Counselling and Testing (PICT) were also discussed. Prevention 
of Mother-to-Child Transmission of Human Immunodeficiency Virus (PMTCT) was 
also discussed at length. Lastly, this chapter focused on the NIMART training, and 
clinical mentorship of the NIMART trained nurses, followed by the clinical pathway 










3. CHAPTER THREE:  
RESEARCH DESIGN AND METHODOLOGY 
3.1. INTRODUCTION 
A quantitative approach was used for the reason that a positivistic paradigm 
systematises the process of knowledge generation. Quantitative research involves 
the collection of measurable data using structured data collection instruments 
(Polit and Beck, 2004). 
3.2. RESEARCH PARADIGM 
A positivistic paradigm was used because it is allied with the quantitative 
approach. According to Polit and Beck (2004), the positivist paradigm is the 
traditional paradigm underlying the scientific approach, which assumes that there 
is a fixed, orderly reality that can be objectively studied, and it is often associated 
with quantitative research.  
3.3. RESEARCH DESIGN 
A quantitative non- experimental descriptive approach and evaluative design was 
used to evaluate the implementation of the Nurse Initiated and Managed 
Antiretroviral Therapy (NIMART) Programme in primary health care clinics in the 
Ugu district of KwaZulu-Natal.  A quantitative, non-experimental, descriptive 
design involves a clear description of a phenomenon (Johnson and Christensen, 
2000). This study’s design consists of a survey which allows for standardised 
questions to be asked. Johnson and Christensen (2000) describe a survey as a 
form of non-experimental research in which data are collected from the 
respondents in order to understand certain characteristics of a population. Non-
experimental designs exclude the manipulation of variables and the random 
assignment to groups (Johnson and Christensen 2000). According to Polit and 
Beck (2004), in a descriptive study, the description of phenomena is another 
important purpose of research and researchers observe, count, define and 
classify. Quantitative description focuses on prevalence, incidence, size, and 
measurable attributes of phenomena. In this study the quantitative design was 
used to ensure the high reliability of the information that was collected and also 
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that similar questions were asked of all the respondents in the form of a 
questionnaire. 
3.4. POPULATION 
In this study the population consisted of PHC nurses trained on NIMART that were 
working in the 56 (54 fixed clinics and 2 CHC’s) primary health care clinics in Ugu 
district. All the 56 clinics in Ugu district were involved in the study. 
Inclusion Criteria: All NIMART trained nurses working in primary health care 
clinics in Ugu district that attended the NIMART Mentorship meeting. 
Exclusion Criteria: PHC Nurses that were not trained on NIMART. 
3.5. DATA SOURCES 
An assessment was conducted to determine whether PHC clinics in Ugu district 
were adequately equipped to implement the NIMART Program. The source 
document was a questionnaire with five parts, namely: demographics, availability 
of latest Antiretroviral Treatment guidelines, implementation of NIMART program, 
knowledge of NIMART and practice of NIMART.  
3.6. DATA COLLECTION TECHNIQUES 
A structured data-collection approach was used. According to Polit and Beck 
(2004), research data for quantitative studies are often collected according to a 
structured plan that indicates what information is to be gathered and how to gather 
it. Most self-administered questionnaires are highly structured. This approach was 
chosen because data were collected from a large sample over a short time. The 
same questions were asked of all the respondents so that there was less chance 
of bias. The researcher designed the questionnaire, which addressed the three 
objectives of the study, after a comprehensive literature review was conducted on 
NIMART. The researcher selected four research assistants to collect data due to 
the large group of participants. The researcher trained the research assistants 
because they did not have prior experience of collecting data. They were trained 
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on how to administer questionnaires and also about the content of the tools, in 
order to be familiar with the research tools.  
Data were collected after the NIMART mentorship meeting that was held on 5th 
September 2016. Invitations were sent to all 56 clinics, inviting NIMART nurses to 
attend the meeting, and each professional nurse represented a single clinic in Ugu 
district. The research assistants administered the research tools to eliminate bias 
since the researcher was involved in the NIMART training, and since the research 
assistants were not biased. All 56 professional nurses from the 56 clinics were 
issued with the questionnaire, informed consent and the information sheet 
explaining the purpose of the study as well as requesting them to participate in the 
study.   
3.7. ISSUES OF RELIABILITY AND VALIDITY 
Burns and Groove (2009) mention that the reliability of a measure denotes the 
consistency of measures obtained in the use of a particular instrument and 
indicates the extent of random error in the measurement method. The instrument 
is said to be reliable if it is administered to the same group of respondents at two 
different times, but still yields the same responses. Burns and Groove (2009), 
state that the validity of an instrument determines the extent to which it actually 
reflects the abstract construct being examined.  
Burns and Groove (2009) point out that equivalence reliability compares two 
versions of the same paper-and-pencil instrument or two observers measuring the 
same event. A test re-test can be done by the pilot study sample group to ensure 
that the same results are yielded after some time. Homogeneity testing examines 
the extent to which all the items in the instrument consistently measure the 
construct. It is a test of internal consistency (Burns and Grooves, 2009). All the 
questionnaires were consistent in asking the same questions and measuring the 
same variables. Administration of the questionnaires was consistent as well. 
Questionnaires were administered to PHC nurses by the research assistants in a 
group setting after the NIMART mentorship meeting.  
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Burns and Groove (2009) state that face validity verifies what the instrument 
looked like, or gives the appearance of measuring the content desired for a study. 
The instrument was pre-tested by the five doctors who were family physicians and 
HAST clinical managers, so as to assess the clarity of the questions, and they all 
recommended that the time taken to administer the instrument was acceptable. 
According to Burns and Groove (2009), content-related validity examines the 
extent to which the method of measurement includes all the major elements 
relevant to the construct being measured, and this evidence is obtained from the 
literature. The researcher designed the instruments from the literature review 
using the literature on NIMART. 
Criterion-reference testing is a comparison of a subject’s score with a criterion of 
achievement that includes the definition of target behaviours. Inclusion criteria 
were the professional nurses from the primary health care clinic who were trained 
in NIMART, because they were initiating patients on Antiretroviral Therapy. 
Exclusion criteria were the professional nurses from the primary health care clinics 
that are not trained in NIMART. Construct validity examines the fit between 
conceptual and operational definitions of variables and determines whether the 
instrument actually measures the theoretical construct that it purports to measure 
(Burns and Groove, 2009).  The variables change from one participant to another, 
such as NIMART knowledge and the practice of NIMART program. For the 
purpose of this study the variables are the knowledge and practice of PHC nurses 
that are NIMART trained. 
3.8. SAMPLING TECHNIQUES 
The sample size was one NIMART trained nurse per clinic that was participating, 
amounting to 56 nurses. Convenient sampling was used to recruit the nurses who 
attended the NIMART mentorship meeting at a central location. All 56 clinics were 
represented. However, nurses from 4 clinics did not meet the study’s inclusion 
criteria which was NIMART training. Hence, they were excluded from the study. 
Initially there were 56 nurses, each one representing a clinic. But only 52 nurses 
met the inclusion criteria out of 56 nurses.  
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Everybody that came to attend the meeting was recruited to represent the clinics. 
The researcher used the advantage that 56 PHC nurses from all 56 PHC clinics 
were attending the second quarter NIMART mentorship meeting and conveniently 
recruited them, provided they complied with the inclusion criteria of being NIMART 
trained.  
Even though all 56 clinics were represented, the minimum sample size was 
calculated using a sample size calculator tool called G-Power to determine the 
minimum number of participants required for the study. The following parameters 
were used:   
a) Effect size = 0,5 (Effect size quantifies the magnitude of the difference 
between population or relationship between population or relationship 
between explanatory and response variables. It is the ratio of population 
standard deviation.) 
b) Type 1 Error = 0,05 (Recommended for observational study design) 
c) Type 2 Error = 0,2 (Recommended for observational study design) 
d) Statistical power of 1-Type 2 (1-0,2) = 0,8 = 80% 
Therefore, on the basis of the above parameters, a minimum sample size of 32 
professional nurses was determined. The response rate was 100%, but only 92% 
of the respondents complied with the inclusion criteria. 
The table below illustrates the number of PHC clinics and CHCs in the Ugu district 




Table 2. Sample Size 
Sub-district Number of Clinics 
1. Umdoni / Vulamehlo sub-district 10 
2. Umzumbe North sub-district 7 + 1 CHC 
3. Umzumbe South sub-district 7 
4. Hibiscus sub-district  13 + 1 CHC 
5. Ezinqoleni sub-district 6 
6. Umuziwabantu sub-district 11 
Total 56 
 
3.9. DATA ANALYSIS AND INTERPRETATION 
The data collected were captured and subsequently analysed using the Statistical 
Package for Social Sciences (SPSS version 21). Descriptive statistics such as 
frequencies, percentages, mean and standard deviation were used to summarise 
results. Responses relating to the knowledge and practice of the NIMART program 
were aggregated to calculate knowledge and practice scores. Tables, bar graphs 
and pie charts were used to present results.   
3.10. ETHICAL CONSIDERATIONS 
The researcher calculated the risk-benefit ratio and concluded that benefits to 
respondents were greater than the risk. There was no risk of harm to respondents 
anticipated in this research project as the questionnaire was assessing knowledge 
of the NIMART programme and the respondents’ identity remained anonymous. 
Respondents benefitted in participating in the study because they were able to 
identify their gaps in the NIMART program, with a quality improvement plan then 
being formulated to breach those gaps. Hence, they were able to improve their 
knowledge and performance. Respondents were not reimbursed for transport 
while participating in this research project because they were already coming to 
attend a planned activity which was the NIMART Mentorship meeting using the 
employer’s transport. The researcher took the advantage of the existing meeting 
to interview the participants. The research results were later shared with the 
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respondents. The researcher’s details were made available to the respondents for 
any further information regarding the study. Respondents were given the 
information leaflet with the researcher’s address and the University of KwaZulu-
Natal Biomedical Research Ethics Committee (UKZN BREC) details, namely, the 
Ethics Committee names, contact numbers, and addresses. If they had any 
concerns or complaints regarding ethics issues, respondents could contact the 
Ethics Committee. 
Application letters for permission to conduct the research study in Ugu district 
were written to the District Manager and the Ugu District Health Ethics Committee. 
Other application letters for permission to conduct the research study in primary 
healthcare clinics in Ugu district were written to the gatekeeper, Clinical and 
Programmes Manager, and lastly to the additional gatekeeper, the HAST Manager 
to collect data during the NIMART mentorship meeting. Final permission was 
granted by the KwaZulu-Natal Department of Health Provincial Health Research 
Committee. Ethical clearance to conduct this research study was obtained from 
the UKZN BREC.  
3.10.1. CONFIDENTIALITY 
A disclaimer was written in the information leaflet stating that all information would 
be kept confidential. Participant’s personal data will be kept in a safe place, 
questionnaires will be archived for five years in the supervisor’s office at the 
University of KwaZulu-Natal (UKZN) and personal information will be stored in a 
database. Confidentiality of data will be maintained by ensuring that no-one other 
than the researcher and statistician will access the participants’ information. There 
will be no linkage of the research data with the respondents as the questionnaires 
were anonymous and the names of respondents were not captured. The purpose 
for which the data will be used is limited to this research project. Respondents’ 
data will not be reused in the future after the completion of this research project. 
After the questionnaires are locked in the supervisor’s office at UKZN for 5 years, 
they will be disposed of following the correct procedures for the disposal of legal 
documents.  
3.10.2. INFORMED CONSENT 
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Respondents who took part in this research project were professional nurses who 
were mentally capable and competent individuals who would understand the 
information given about the research project, as well as the objectives. The 
information leaflet was administered to the respondents to read and keep. 
Respondents were provided with all the information they needed to know about 
the research project in order for them to make an informed consent. The research 
assistants also provided additional information by answering all the questions that 
the potential respondents had. 
The respondents that were interested in participating gave their informed consent 
to participate in the study and were then enrolled to be the study respondents. 
Consent was voluntary, respondents were at liberty to decide if they wanted to 
participate in this research project or not, and they also had a right to withdraw 
their consent at any time. The research assistants signed as witnesses. Important 
elements about the research project were disclosed to prospective respondents, 
such as the aims and methods of the research project as well as the researcher’s 
identity.  
3.10.3. DATA DISSEMINATION 
Plans to inform the respondents of the research results were as follows. The 
researcher shared the findings of the research project with all relevant 
stakeholders who were going benefit from it. Firstly, the findings were shared with 
the District Manager, Deputy District Manager, District HAST Manager and all 
other Programme Managers. Lessons learned with regard to the progress of the 
NIMART Program in the Ugu district were shared with stakeholders. Thereafter, 
the findings were shared with the respondents and clinic Operational Managers 
during the NIMART mentorship meeting in 2017. Lessons learned have helped the 
respondents and Operational Managers in identifying their gaps in the NIMART 
program. Findings of this research project assisted the District Training 
Coordinator to plan for the trainings, which will enhance the participants’ skills and 
knowledge of the NIMART program and hence improve the participants’ 
performance and health outcomes.  
3.11. PRE-TEST OR PILOT STUDY 
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Burns and Groove (2009) state that a pilot study is a smaller version of a proposed 
study conducted to develop or refine the methodology, such as the treatment, 
instrument, or data collection process. The purpose of the pilot study is to identify 
errors in the research instruments. A pilot study was conducted on a small sample 
of 5 respondents who were not part of the study sample. The research instrument 
was pretested on 5 doctors who are District Family Physicians and HAST Clinical 
Managers, to ensure that the instructions were clear and the questions asked 
were relevant and unambiguous. They all recommended that the time taken to 
administer the instrument was acceptable. A test retest could have been 
performed at any time to ensure that the same responses were yielded.   
3.12. CONCLUSION 
This chapter described the research design and methodology, including the study 
population and the sampling technique. Data sources and data collection 
techniques were also discussed as well as issues of the reliability and validity of 
the data collection instrument and the pretesting of it. Ethical considerations 
including confidentiality, informed consents and the plan for data dissemination 




4. CHAPTER FOUR:  
DATA PRESENTATION AND ANALYSIS 
4.1. INTRODUCTION 
This chapter presents the findings of the study in the form of data. In addition, it 
presents the data analysis. The study sought to answer the following research 
questions: 
1. What Antiretroviral Therapy guidelines are available at the primary healthcare 
clinics in Ugu district? 
2. What is the status of Ugu district facilities in providing HIV counselling, testing 
and treatment? 
3. What is the level of knowledge and practice of professional nurses towards 
NIMART program?  
 
A sample size of 56 participants from the 56 PHC clinics was invited to participate 
in the study. All PHC clinics in Ugu district were represented. However, four 
professional nurses were excluded according to the exclusion criteria, they did not 
meet the inclusion criteria of being trained on the NIMART course. Hence, only 52 
participants were enrolled in the study. The research questionnaire was 
administered to the 52 professional nurses who are NIMART trained. All 52 
respondents completed the questionnaire. 
4.2. DATA CAPTURE TECHNIQUES 
The data collected were captured and subsequently analysed using the Statistical 
Package for Social Sciences (SPSS version 21). Descriptive statistics such as 
frequencies, percentages, mean and standard deviation were used to summarise 
the results. The data are presented by means of frequency tables, bar graphs and 
pie charts and are organised below according to the five parts of the 
questionnaire: Part 1 –Demographics, Part 2 –Availability of latest Antiretroviral 
Treatment guidelines, Part 3 –Implementation of NIMART programme, Part 4 –
Knowledge of NIMART and Part 5 –Practice of NIMART. Data analysis from the 
questionnaire was as follows. 
53 
 
4.3. PART 1: DEMOGRAPHICS 
4.3.1. ARE YOU A PROFESSIONAL NURSE? 
 
Table 3. Frequencies per Professional Category 
Professional Nurse N Frequency      Percentage 
YES 56          56          100% 
 NO 56          0           0% 
 
Of the respondents that consented to participate in the study, 100% (n=56) were 
professional nurses working in primary healthcare clinics.  
4.3.2. ARE YOU TRAINED IN THE NIMART COURSE? 
 
Table 4. Frequencies of Professional Nurses trained in the NIMART Course 
NIMART Training N Frequency      Percentage 
YES 56          52          93% 
 NO 56          4          7% 
 
Of the respondents who work at PHC clinics, 93% (n=52) were trained in the 
NIMART course, as compared to 7% (n=4), who were not trained in the NIMART 
course and were excluded according to the exclusion criteria. A total of 52 




4.3.3. CURRENT POSITION 
 
Figure 5. Designations of Respondents 
The sample (n=52) of NIMART trained Nurses consisted of PHC Operational 
Managers, 54% (n=28); Clinical Nurse Practitioners, 31% (n=16) and Professional 
Nurses, 15% (n=8). 
4.3.4. NUMBER OF PROFESSIONAL NURSES IN YOUR CLINIC 
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The findings of the study represented in the bar graph above indicate that in the 
total sample (n=52) of PHC clinics represented, 16% (n=8) consisted of one to two 
Professional Nurses; 42% (n=22) consisted of three to five Professional Nurses; 
25% (n=13) consisted of six to 10 Professional Nurses and 17% (n=9) consisted of 
more than 10 Professional Nurses. 
4.3.5. NUMBER OF NIMART TRAINED NURSES IN YOUR CLINIC 
 
Figure 7. Number of NIMART trained Nurses in each clinic 
The findings of the study represented in the pie chart above indicate that in the 
total sample (n=52) of PHC clinics represented, 19% (n=10) consisted of one 
NIMART Nurse; 23% (n=12) consisted of two NIMART Nurses; 58% (n=30) 
consisted of three NIMART Nurses or more. 
4.4. PART 2: AVAILABILITY OF LATEST ANTIRETROVIRAL TREATMENT 
GUIDELINES 










Figure 8. Frequencies of Availability of ART Guidelines 
This bar graph presents the availability of ART guidelines in PHC clinics: 98% (n=51) 
reported that ART guidelines were available in their clinics, and only 2% (n=1) reported 
that ART guidelines were not available in their clinic.  
4.4.2. WHICH ART GUIDELINES ARE AVAILABLE IN YOUR CLINIC? 
 
Figure 9. Version of ART guidelines available in PHC clinics 
This pie chart above presents the version of ART guidelines that were available in PHC 



















(n=8) reported that 2014 ART guidelines were available in their clinic and 83% (n=43) 
reported that the latest 2015 ART guidelines were available in their clinics.  
4.5. PART 3: IMPLEMENTATION OF NIMART 
4.5.1. DO PROFESSIONAL NURSES INITIATE ADULTS AND MANAGE ART 
IN THEIR CLINIC? 
 
Figure 10. Clinics that initiate adults on ART 
Of the respondents who were initiating Antiretroviral Therapy in their clinics, 98% 
(n=51) of the clinics were initiating adults on ART, as compared to 2% (n=1) of the 








4.5.2. ARE CHILDREN INITIATED ON ART IN YOUR CLINIC? 
 
Figure 11. Clinics that initiate Children on ART 
Of the respondents who were initiating Antiretroviral Therapy in their clinics, 71% 
(n=37) of the clinics were initiating children on ART, as compared to 29% (n=15) 
of the clinics who were not initiating children on ART. 
4.5.3. WHO INITIATES CHILDREN ON ART IN YOUR CLINIC? 
 
Figure 12. Initiator of children on ART 
Of the respondents who were initiating children on Antiretroviral Therapy in their 



















(n=4) of the clinic’s children were initiated by the clinic’s visiting doctor, 8% (n=4) 
of the clinics children were initiated by the roving team doctor and 54% (n=28) of 
the clinics children were initiated by professional nurses. 
4.6. PART 4: KNOWLEDGE OF NIMART – ART REGIMENS 
4.6.1. WHAT IS THE FIRST LINE ART REGIMEN FOR CHILDREN < 
3YEARS OR 10KG? 
 
Figure 13. First Line ART regimen for children < 3yrs 
This bar graph above presents the first line ART regimen for children under three 
years: 90% (n=47) knew the correct ART regimen and the other 10% (n=5) did not 
know the correct regimen. The results indicated a gap in the nurse’s knowledge of 
First Line ART regimen for children under three years. 
4.6.2. WHAT IS THE FIRST LINE ART REGIMEN FOR CHILDREN >3 YEARS 

















Figure 14. First Line ART regimen for children > 3yrs up to adolescents <15 
years or <40kg? 
This bar graph above presents the first line ART regimen for children three years 
and older up to adolescents less than 15 years, 76% (n=39) knew the correct ART 
regimen; the other 24% (n=13) did not know the correct regimen for children three 
years and older, which is an area of concern. 
4.6.3. WHAT IS THE FIRST LINE ART REGIMEN FOR ADOLESCENTS AND 
ADULTS? 
 


























This bar graph above presents the first line ART regimen for adolescents and 
adults: a total of 98% (n=51) knew the correct ART regimen, which is TDF + FTC 
+ EFV, as compared to 2% (n=1) who did not know the correct regimen.  
4.6.4. WHAT IS THE ISONIAZID PREVENTIVE THERAPY REGIMEN FOR 
ADULTS? 
 
Figure 16. Adults Isoniazid Preventive Therapy regimen 
Of the respondents, 67% (n=35) knew about the adults Isoniazid Preventive 
Therapy, which is administering Isoniazid 5mg/kg/day and Pyridoxine 25mg/day; 
while 31% (n=16) did not know the correct IPT regimen and reported using 
Isoniazid only; and 2% (n=1) also did not know the correct regimen, and reported 
using Pyridoxine only. 


















Figure 17. Criteria for Cotrimoxazole Preventive Therapy 
Of the respondents, 73% (n=38) knew the criteria for initiating Cotrimoxazole 
Preventive Therapy which is at a CD4 count < 350; WHO clinical Stage 2, 3, &4 
and HIV/TB co-infection. 19% (n=10) did not know the correct criteria, and 
reported CD4 count < 350 only; 4% (n=2) also did not know the correct criteria, 
and reported WHO clinical stage 2, 3 and 4 only; and 4% (n=2) did not know the 



















4.7. PART 5: PRACTICE OF NIMART – ART ELIGIBILITY CRITERIA AND 
LABORATORY BLOOD TESTS 
4.7.1.  PATIENTS WITH WHO CLINICAL STAGES 3 & 4 ARE ELIGIBLE FOR 
ART INITIATION REGARDLESS OF THEIR CD4 COUNT 
 
Figure 18. ART Eligibility Criteria: WHO stages 3 & 4 eligible 
Of the respondents, 98% (n=51) agreed with the statement that patients with 
WHO clinical stages 3 & 4 are eligible for Antiretroviral Therapy initiation 
regardless of their CD4 count; 2% (n=1) disagreed and 0% (n=0) were unsure. 
4.7.2. PATIENTS WITH CD4 COUNTS OF OR LESS THAN 500 CELLS/MM3 



















Figure 19. ART Eligibility Criteria: CD4 count < 500 not eligible 
Of the respondents, 98% (n=51) disagreed with the statement that patients with a 
CD4 count of or less than 500 cells/mm3 are not eligible for Antiretroviral Therapy 
initiation; 4% (n=2) did not know and 2% (n=1) were unsure.   
4.7.3. CHILDREN LESS THAN 5 YEARS OLD ARE ELIGIBLE FOR ART 
INITIATION REGARDLESS OF THEIR CD4 COUNT OR WHO 
CLINICAL STAGING 
 

































Of the respondents, 92% (n=48) agreed with the statement that children less than five 
years old are eligible for Antiretroviral Therapy initiation regardless of their CD4 count or 
WHO clinical staging; 8% (n=4) disagreed and 0% (n=0) were unsure.   
4.7.4. PREGNANT OR BREASTFEEDING MOTHERS ARE NOTELIGIBLE 
FOR IMMEDIATE ART INITIATION 
 
Figure 21. ART Eligibility Criteria: Pregnant &breastfeeding mothers not 
eligible 
Of the respondents, 94% (n=49) disagreed with the statement that pregnant or 
breastfeeding mothers are not eligible for immediate Antiretroviral Therapy initiation; 6% 
(n=3) did not know and 0% (n=0) were unsure.   
4.7.5.  PATIENTS WHO ARE TB / HIV CO-INFECTED SHOULD BE 
INITIATED ON ANTI-TB DRUGS FIRST, THEN INITIATED ON ART 
WITHIN 8 WEEKS OR 2 WEEKS IF THEIR CD4 COUNT IS LESS 



















Figure 22. ART Eligibility Criteria: TB / HIV Co-Infected Eligible 
Of the respondents, 98% (n=51) agreed with the statement that patients who are TB / 
HIV co-infected should be initiated on Anti-TB drugs first, then initiated on Antiretroviral 
Therapy within eight weeks or two weeks if their CD4 count is less than 50 cells/mm3; 
0% (n=0) disagreed and 2% (n=1) were unsure.   
4.7.6. WHEN WOULD YOU TAKE BLOOD FOR DETERMINING THE CD4 
COUNT? 
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The above pie chart represents the frequencies of the responses to when CD4 
count blood tests should be taken. 72% (n=37) reported that CD4 count blood 
tests are taken at baseline, 12 months then annually; 18% (n=9) reported that 
CD4 count blood tests are taken at 12 months then annually; and 10% (n=5) 
reported that CD4 count blood tests are taken at six months, 12 months then 
annually. In summary, the majority of the participants 72% (n=37) knew when 
blood for CD4 count tests should be taken, whereas 18% (n=9) and 10% (n=5) did 
not know.  
4.7.7. WHEN WOULD YOU TAKE BLOOD FOR DETERMINING VIRAL 
LOAD? 
 
Figure 24. Viral Load blood test 
The above pie chart represents the frequencies of the responses to when viral 
load blood tests should be taken. 76% (n=39) reported that viral load blood tests 
are taken at six months, 12 months, then annually; 18% (n=9) reported that viral 
load blood tests are taken at baseline, six months, 12 months then annually; and 
6% (n=3) reported that viral load blood tests are taken at baseline, at three 
months, six months and then annually. In summary, the majority of the participants 
76% (n=39) knew when blood for viral load tests should be taken, whereas 18% 
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Baseline, 6 Months, 12
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This chapter presented the data obtained from the study. The data were analysed 
and presented in the form of tables, bar graphs and pie charts. In an attempt to 
answer the research questions, the findings of the study presented that 98% 
(n=51) reported that ART guidelines were available in their clinics, and only 2% 
(n=1) reported that ART guidelines were not available in their clinic.83% (n=43) 
reported that the latest 2015 ART guidelines were available in their clinics. With 
regard to NIMART implementation, 98% (n=51) of the clinics were initiating adults 
on ART, as compared to 2% (n=1) of the clinics that were not initiating adults on 
ART. Chapter Five will discuss the findings, make recommendations, and give the 
limitations and conclusions of the study.  
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5. CHAPTER FIVE:  
DISCUSSION OF FINDINGS, AND RECOMMENDATIONS, LIMITATIONS 
AND CONCLUSIONS 
5.1. INTRODUCTION 
This chapter discusses the summary of the study findings with regard to the 
availability of the latest ART guidelines, implementation of NIMART and 
knowledge of the NIMART program. It also discusses the recommendations, 
limitations and conclusions of the study. 
The purpose of this study was to conduct an Implementation Evaluation Study of 
the Nurse Initiated and Managed Antiretroviral Therapy (NIMART) program in 
primary healthcare clinics in the Ugu district of KwaZulu-Natal. The objectives 
were to evaluate the availability of the latest Antiretroviral Therapy guidelines, to 
evaluate the implementation of the Nurse Initiated and Managed Antiretroviral 
Therapy (NIMART) program and to evaluate the knowledge and practice of 
professional nurses towards the NIMART program in the clinics of the Ugu district. 
The researcher selected four research assistants to collect data and to eliminate 
bias, as the researcher was the Training Coordinator in the Ugu district. The 
researcher trained the research assistants, because they did not have prior 
experience on data collection, to use the questionnaires and to administer it. 
Furthermore, the researcher trained the research assistants on the information 
leaflet and informed consent. The research assistants provided the information 
about the research study and also assisted in obtaining informed consent. 
Data were collected after the NIMART mentorship meeting that was held on the 5th 
of September 2016. The research assistants administered the research tools to 
eliminate bias as they were neutral. NIMART nurses from all 56 clinics were 
invited to attend the meeting. Each professional nurse represented a single clinic 
in the Ugu district.  
5.2. DISCUSSION OF THE FINDINGS 
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The findings of this study revealed that the majority of Primary Health Care clinics 
in the Ugu district were implementing the guidelines on NIMART by shifting the 
task of initiating ARVs to the nurses and by decentralising the services of HIV 
counselling, testing and treating to the clinics. There is a great need to train more 
nurses on NIMART, as it was also evidenced by the findings of this study that HIV-
positive people in the Ugu district benefited by accessing ARV’s in good time 
because the nurses were also providing treatment. That Quality HIV care was 
being provided in the Ugu district was shown by the results of this study indicating 
that guidelines on NIMART were available on almost all the clinics in the district 
and that the nurses had knowledge of ARV regimens, blood tests for CD4 and 
viral load and preventive therapy.  
The findings of the study are discussed below in relation to the demographics of 
nurses and the three research questions. 
5.2.1. DEMOGRAPHICS OF NURSES 
The results of this study revealed that professional nurses from all the primary 
health care clinics in the Ugu district participated in the study. However, not all 56 
professional nurses were trained in NIMART. Four professional nurses were not 
trained in NIMART and were excluded from the study due to the exclusion criteria. 
Hence, out of 56 professional nurses only 52 were enrolled in the study. 
Respondents that were trained in NIMART consisted of different nursing 
categories namely: PHC Operational Managers, Clinical Nurse Practitioners and 
Professional Nurses. All these categories are however professional nurses. 
Primary healthcare clinics had staffing challenges, operating with only two 
professional nurses. Other clinics, which were mainly the 24 hour clinics and the 
CHCs, had more than 10 professional nurses. All the clinics had at least one 
NIMART trained nurse and some clinics had more than one. If there is an 
adequate number of nurses and the nurse-patient ratio is maintained, quality 




5.2.2. WHAT ANTIRETROVIRAL THERAPY GUIDELINES ARE AVAILABLE AT 
THE PRIMARY HEALTHCARE CLINICS IN THE UGU DISTRICT? 
With regard to the availability of ART guidelines in PHC clinics, they were 
available in all PHC clinics in the Ugu district, although one respondent reported 
that the clinic had the outdated 2013 ART guidelines. The research that was 
conducted confirmed what Colvin (2010) had found: that nurses, patients and 
doctors highly accepted NIMART, and also that managers and nurses expressed 
confidence in their ability to apply the guidelines and deliver ART successfully. 
There are different versions of ART guidelines that are available in PHC clinics in 
the Ugu district. New developments have been added in the latest guidelines. A 
few clinics reported that the 2014 ART guidelines were available in their clinics, 
which is still good enough since the 2014 guidelines were a draft of the latest 
guidelines of 2015.  A majority of clinics reported that the current and latest 2015 
ART guidelines were available in their clinics with the title of National Consolidated 
Guidelines for the Prevention of Mother-to-Child Transmission of HIV (PMTCT) 
and the Management of HIV in Children, Adolescents and Adults (April 2015).  
5.2.3. WHAT IS THE STATUS OF UGU DISTRICT FACILITIES IN PROVIDING 
HIV COUNSELLING, TESTING AND TREATMENT? 
The majority of the professional nurses who work at the Primary Health Care 
clinics in the Ugu district are trained in NIMART. Only 4 clinics had nurses that 
were not trained in NIMART. Hence, 52 PHC clinics in the Ugu district are 
compliant with the presidential mandate that was announced on the 1st December 
2009 that all PHC clinics should provide Antiretroviral Therapy and nurses must be 
trained in NIMART. In2010, there was a presidential mandate that ARVs should be 
made available in all public health facilities and nurses should be trained to 
prescribe and manage patients on these drugs (Nyasulu et al., 2013). 
Professional nurses in all primary healthcare clinics in the Ugu district, except one, 
were initiating adults and children on Antiretroviral Therapy, although in half of the 
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clinics paediatric ART initiation is still done by the hospital or roving teams of 
doctors and professional nurses who continue with the management. 
5.2.4. WHAT IS THE LEVEL OF KNOWLEDGE AND PRACTICE OF 
PROFESSIONAL NURSES TOWARDS THE NIMART PROGRAM?  
KNOWLEDGE OF NIMART–ART REGIMENS 
The majority of NIMART nurses, 90% (n=47), knew the correct first line ART 
regimen for children under three years old according to the Department of Health 
(2015). The other 10% (n=5) did not know the correct regimen. The results 
indicated a gap in the nurse’s knowledge of the first line ART regimen for children 
under three years old. Even fewer NIMART nurses, 76% (n=39), knew the correct 
first line ART regimen for children three years and older. This includes ages up to 
and including adolescents 15 years old (DOH, 2015). 24% (n=13) did not know the 
correct first line ART regimen for children three years and older, including 
adolescents below 15 years, which is an area of concern. The majority of NIMART 
nurses, 98% (n=51), were knowledgeable about the correct first line ART regimen 
for adolescents and adults which is provided in the form of Fixed-dose 
Combination (FDC) (DOH, 2015). Only 2% (n=1) did not know the correct 
regimen. A large number of NIMART nurses were knowledgeable about the 
Isoniazid preventive therapy and the criteria for initiating Cotrimoxazole preventive 
therapy. There were, however, nurses who were not knowledgeable about the two 
preventive therapies namely, Isoniazid preventive therapy and Cotrimoxazole 
preventive therapy.  
PRACTICE OF NIMART - ART ELIGIBILITY CRITERIA  
The NIMART nurses in the Ugu district were knowledgeable about the ART 
eligibility criteria according to the National Consolidated Guidelines for PMTCT 
(2015), but there were still nurses trained in NIMART who were unsure or did not 
know the ART eligibility criteria.  
PRACTICE OF NIMART - LABORATORY BLOOD TESTS 
Lastly, the study evaluated the knowledge of professional nurses trained in 
NIMART with regards to the CD4 count and viral load blood tests. NIMART trained 
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nurses in the Ugu district know when the CD4 count and viral load blood test 
should be done. According to the DOH (2015), baseline and routine clinical and 
laboratory assessment for late adolescents and adults: CD4 counts should be 
taken at diagnosis to identify eligibility for ART and patients on ART, CD4 counts 
should be checked at 12 months, then annually (if clinically indicated), in order  to 
monitor immune response to ART. Viral load should be checked once the patient 
is already on ART at month 6, and month 12 on ART and then every 12 months, to 
identify treatment failures and problems with adherence.  
5.3. LIMITATIONS TO THE STUDY 
Not all NIMART nurses were assessed: only one per clinic was.  More accurate 
results of the nurses’ knowledge on the NIMART program could have been 
obtained if all NIMART trained nurses had been assessed.  
Four clinics were excluded from the study because they had sent nurses to attend 
the NIMART mentorship meeting that were not NIMART trained and so they did 
not meet the inclusion criteria. Hence, there was a discrepancy with the sample 
size because initially it was 56 clinics, yet 52 clinics were evaluated. Nurses from 
clinics in only one district were included in the study sample which will limit the 
generalisability of the findings to other districts. 
Assessing the availability of guidelines for NIMART using the reported results, the 
researcher could not verify this response by physically looking at the guidelines 
since she did not visit the clinics, but had to accept the information that was 
provided in the questionnaires. 
5.4. RECOMMENDATIONS 
In view of the findings of the study, the researcher made the following 
recommendations for the implementation of NIMART. 
5.4.1. RECOMMENDATIONS FOR MANAGEMENT 
Motivation for the creation of professional nurses’ posts must be done by the 
District Human Resource Manager and the clinics’ Operational Managers. This will 
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ensure the even distribution of staff in PHC clinics and improve the shortage of 
staff. 
The District HAST Manager and clinics’ Operational Managers must ensure that 
the latest 2015 National Consolidated Guidelines for PMTCT are available in all 
the PHC clinics. 
5.4.2. RECOMMENDATIONS FOR EDUCATION 
NIMART course should continue and more nurses must be trained in NIMART so 
that the target of 15 million HIV positive people accessing Antiretroviral Therapy is 
reached, and also for health facilities to cope with the universal access to 
treatment. 
All the nurses that are NIMART trained should receive mentorship after the 
training so that they become competent and confident in initiating and managing 
HIV-positive patients on ART. 
The District Training Coordinator must arrange a workshop fthe2015 National 
Consolidated Guidelines to refresh NIMART nurses about ART regimens and 
blood tests to be done, as well as learning the ART eligibility criteria.  
  
5.4.3. RECOMMENDATIONS FOR RESEARCH 
The findings of this study revealed that there were some gaps in the nurses’ 
knowledge around ART regimens, blood tests and eligibility criteria. This study can 
be used as a baseline to evaluate all the professional nurses trained in NIMART in 
the Ugu district. 
5.5. CONCLUSION 
The study was conducted in the Ugu district of KwaZulu-Natal to evaluate the 
implementation of the NIMART program. The study revealed that in 98% (n=51) of 
the clinics in Ugu district nurses are initiating adults on ART and only 2% (n=1) are 
still being initiated by a doctor. Furthermore, the majority of respondents indicated 
that children are initiated on ART in their clinics, while some respondents reported 
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that in their clinics children are still initiated by the clinic visiting doctor or hospital 
doctor. The findings indicated that 98% (n=51) clinics have the latest ART 
guidelines available, while only 2% (n=1) of clinics indicated that they have 
outdated ART guidelines available in the clinic. The study revealed that most 
respondents knew the correct ART regimens, ART eligibility criteria and when 
bloods for CD4 count and viral load should be taken, while there are still some 
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APPENDIX 1: RESEARCH TOOLS 
Instrument 1: Questionnaire 
 
AN IMPLEMENTATION EVALUATION STUDY OF NURSE INITIATED AND 
MANAGED ANTIRETROVIRAL THERAPY (NIMART) PROGRAM IN PRIMARY 
HEALTH CARE CLINICS IN THE UGU DISTRICT OF KWAZULU-NATAL. 
 PART 1: DEMOGRAPHICS   
_____________________________________________________________________ 
1. Are you a Professional Nurse? 
 
Yes                       No 
   
 
2. Are you trained on NIMART Course? 
 
 Yes                           No    
 
 
3. Current Position 
  
 PHC Coordinator                           Clinical Nurse Practitioner 
  
 
  Operational Manager                 Professional Nurse  
 
 
4. Number of Professional Nurses in your clinic 
 
 1 - 2                                6 - 10   
 











5. Number of NIMART trained Professional Nurses in your clinic 
 None                                2   
 
 1                              3 + 
 
 
PART 2: AVAILABILITY OF LATEST ANTIRETROVIRALTREATMENT 
GUIDELINES 
     ___________________________________________________________________________ 
 
1. Are Antiretroviral Treatment Guidelines available in your clinic? 
 
 Yes                             No  
   
 
 
2. Which Antiretroviral Therapy Guidelines are available in your clinic? 
 
 None                                2014   
 
 2013                              2015 
 
 
PART 3: IMPLEMENTATION OF NIMART  
     ___________________________________________________________________________ 
 
1. Do Professional Nurses initiate adults and manage Antiretroviral Treatment in your 
clinic? 
 










2. Are children initiated on Antiretroviral Treatment in your clinic? 
 
 Yes                             No  
 
 
3. Children in your clinic are initiated on Antiretroviral Treatment by 
 
  Doctor at hospital                         Clinic visiting Doctor   
 
Roving Team Doctor                 Professional Nurse  
 
PART 4: KNOWLEDGE OF NIMART – ART REGIMENS  
     ___________________________________________________________________________ 
Please choose the best correct answer of the following: 
1. What is First Line ART Regimen to start all infants and children under 3 yrs or 10kg on? 
(a) ABC + 3TC + EFV 
(b) TDF + FTC + EFV 
(c) ABC + 3TC + LPV/r 
 
2.  What is First Line ART Regimen to start all infants and children over 3 yrs or 10kg on? 
(a) ABC + 3TC + EFV 
(b) TDF + FTC + EFV 
(c) ABC + 3TC + LPV/r 
 
 
3. What is First Line ART Regimen to start all adults on? 
(a) ABC + 3TC + EFV 
(b) TDF + FTC + EFV 








4. What is the Isoniazid Preventive Therapy (IPT) Regimen for adults? 
(a) INH 5mg/kg/day (max 300mg/day) 
(b) Pyridoxine 25mg/day 
(c) All of the above 
 
 
5. When would you start Cotrimoxazole Preventive Therapy (CPT)? 
(a) CD4 count is less than 350 cells/mm3 
(b) WHO Clinical Stage 2, 3 and 4 
(c) HIV/TB co-infection 




PART 5: PRACTICE OF NIMART – ART ELIGIBILITY CRITERIA &LABORATORY 
BLOOD TESTS 
__________________________________________________________________________________ 
ART ELIGIBILITY CRITERIA 
Please state how you agree or disagree with each of the following: 
 Agree Disagree Not  Sure 
1. Patient with WHO Clinical Stage 3 & 4  
is eligible for ART initiation regardless of 
CD4 count. 
   
2.Patient with CD4 count of or less than  
500 cells/mm3 is not eligible for ART initiation. 
   
3.Children less than 5 years are 
eligible for ART initiation regardless of  
CD4 count or WHO Clinical Staging.  
   
4.Pregnant or breastfeeding mothers 
are not eligible for immediate ART initiation.  
   
5.Patients who are TB / HIV co-infected 
should be initiated on Anti-TB drugs first, 
then initiated on ART within 8 weeks or  
2 weeks if CD4 count is less than  
50 cells/mm3. 




LABORATORY BLOOD TESTS 
 
Please choose the best correct answer of the following: 
 
1. When would you take bloods for CD4 count? 
(a) At 12 months then annually 
(b) At baseline; 12 months then annually 
(c) At 6 months; 12 months then annually 
 
2. When would you take bloods for Viral load? 
(a)At baseline; 3 months and 6 months then annually 
(b)At baseline; 6 months; 12 months then annually 
(c)At 6 months; 12 months then annually 
 






































APPENDIX 7: LETTER REQUESTING PERMISSION TO CONDUCT A 
RESEARCH STUDY FROM UGU HEALTH DISTRICT OFFICE 
         7 Weaver Road 
         Yellowwood Park 
         4004 
         27 March 2015 
 
The District Manager 
Ugu Health District Office 
Private Bag X735  
Port Shepstone  
4240 
 
Dear Mr Nguza, 
 
APPLICATION FOR PERMISSION TO CONDUCT A RESEARCH STUDY IN UGU 
DISTRICT 
 
Research Topic: An Implementation Evaluation Study of A Nurse Initiated and 
Managed Antiretroviral Therapy (NIMART) Program In Primary Health Care Clinics 
in the Ugu district of KwaZulu-Natal. 
I hereby kindly request permission to conduct a research study in Ugu district. I’m a lady 
of 38 years, currently studying Masters in Nursing Management – Coursework in the 
School of Nursing at the University of KwaZulu-Natal. Part of the requirements for the 
Masters Degree is to conduct a Research Project. The study of my interest is an 
Implementation Evaluation Study of Nurse Initiated and Managed Antiretroviral Therapy 
(NIMART) Program in Primary Health Care Clinics in the Ugu district of KwaZulu-Natal. 
Background of this research study is based on the presidential mandate announced by 
President Jacob Zuma during the World AIDS day celebration on 1 December 2009. That 
is, to decentralize HIV treatment to primary health care centres with the ultimate goal of 
universal access to HIV treatment, through the Nurse Initiated and Managed Antiretroviral 
Therapy (NIMART) strategy. 
Objectives of this research study seek to: 
1. Evaluate the availability of latest Antiretroviral Therapy Guidelines in the 
Primary Health Care clinics at Ugu district.  
2. Evaluate the implementation of Nurse Initiated and Managed Antiretroviral 
Therapy (NIMART) program at the clinics in Ugu district. 
3. Evaluate the knowledge and practice of Professional nurses towards NIMART 




Ugu district Primary Health Care clinics from all six Sub-districts and two CHC’s will be 
used as the population of this study. All 54 clinics and two CHC’s will be evaluated. 
Professional Nurses that are NIMART trained will be randomly selected from each clinic 
and CHC in all sub-districts. A total of 56 nurses will be participating in this research 
study.  
This research study does not intend to disturb the service deliveryas the participants will 
be completing a Questionnaire with five parts namely: Demographics, Availability of latest 
Antiretroviral Treatment Guidelines, Implementation of NIMART Program, Knowledge of 
NIMART and Practice of NIMART. Completion of the Questionnaire can take only 30 
minutes after the NIMART mentorship meeting. Questionnaire attached please refer to 
Appendix 5. 
I declare that this research project is not sponsored, it is self-funded by the researcher. 
Permission to conduct this research study will be obtained from University of KwaZulu-
Natal Biomedical Research Ethics Committee (UKZN BREC). If you have any concerns or 
complaints regarding ethics issues please contact Ethics Committee (UKZN BREC) at 
(031) 260 4769. 
Please find attached the following:  
A copy of the research proposal including Participant’s information sheet, Informed 
Consent; and a Questionnaire. 
Your kind consideration of the application will be highly appreciated.  
Thank you. 
Kind Regards, 
Researcher : Mrs Pearl Xaba 
 Work : (039) 688 3000 
 Cell : 083 350 3620 
 Email :pearl.xaba8@gmail.com / pearl.xaba@kznhealth.gov.za  
 
Research Supervisor : Dr J. Kerr 
 Work : (031) 260 1432  
 Email :kerrj@ukzn.ac.za 
 
UKZN BREC Committee : 
Tel: 031 260 4769 





APPENDIX 8: LETTER REQUESTING PERMISSION TO CONDUCT A 
RESEARCH STUDY FROM THE GATEKEEPER 
7 Weaver Road 
         Yellowwood Park 
         4004 
         23 October 2015 
 
The Clinical and Programmes Manager 
Ugu Health District Office 
Private Bag X735  
Port Shepstone  
4240 
 
Dear Mrs Ntuli, 
 
APPLICATION FOR PERMISSION TO CONDUCT A RESEARCH STUDY IN UGU 
DISTRICT 
Research Topic :An Implementation Evaluation Study of A Nurse Initiated and 
Managed Antiretroviral Therapy (NIMART) Program In Primary Health Care Clinics 
in the Ugu district of KwaZulu-Natal. 
I hereby kindly request permission to conduct a research study in Ugu district. I’m a lady 
of 38 years, currently studying Masters in Nursing Management – Coursework in the 
School of Nursing at the University of KwaZulu-Natal. Part of the requirements for the 
Masters Degree is to conduct a Research Project. The study of my interest is an 
Implementation Evaluation Study of Nurse Initiated and Managed Antiretroviral Therapy 
(NIMART) Program in Primary Health Care Clinics in the Ugu district of KwaZulu-Natal. 
Background of this research study is based on the presidential mandate announced by 
President Jacob Zuma during the World AIDS day celebration on 1 December 2009. That 
is, to decentralize HIV treatment to primary health care centres with the ultimate goal of 
universal access to HIV treatment, through the Nurse Initiated and Managed Antiretroviral 
Therapy (NIMART) strategy. 
Objectives of this research study seek to: 
1. Evaluate the availability of latest Antiretroviral Therapy Guidelines in the 
Primary Health Care clinics at Ugu district.  
2. Evaluate the implementation of Nurse Initiated and Managed Antiretroviral 
Therapy (NIMART) program at the clinics in Ugu district. 
3. Evaluate the knowledge and practice of Professional nurses towards NIMART 





Ugu district Primary Health Care clinics from all six Sub-districts and two CHC’s will be 
used as the population of this study. All 54 clinics and 2 CHC’s will be evaluated. 
Professional Nurses that are NIMART trained will be randomly selected from each clinic 
and CHC in all sub-districts. A total of 56 nurses will be participating in this research 
study.  
This research study does not intend to disturb the service deliveryas the participants will 
be completing a Questionnaire with five parts namely: Demographics, Availability of latest 
Antiretroviral Treatment Guidelines, Implementation of NIMART Program, Knowledge of 
NIMART and Practice of NIMART. Completion of the Questionnaire can take only 30 
minutes after the NIMART mentorship meeting. Questionnaire attached please refer to 
Appendix 5. 
I declare that this research project is not sponsored, it is self-funded by the researcher. 
Permission to conduct this research study will be obtained from University of KwaZulu-
Natal Biomedical Research Ethics Committee (UKZN BREC). If you have any concerns or 
complaints regarding ethics issues please contact Ethics Committee (UKZN BREC) at 
(031) 260 4769.  
Please find attached the following:  
A copy of the research proposal including Participant’s information sheet, Informed 
Consent and a Questionnaire. 




Researcher : Mrs Pearl Xaba 
 Work : (039) 688 3000 
 Cell : 083 350 3620 
 Email :pearl.xaba8@gmail.com / pearl.xaba@kznhealth.gov.za  
 
Research Supervisor : Dr J. Kerr  
 Work : (031) 260 1432  
 Email :kerrj@ukzn.ac.za 
 
UKZN BREC Committee : 
Tel: 031 260 4769 





APPENDIX 9: LETTER REQUESTING PERMISSION TO COLLECT DATA 
ATTHE NIMART MENTORSHIP MEETING FROM THE ADDITIONAL 
GATEKEEPER 
 
7 Weaver Road 
        Yellowwood Park 
        4004 
        28 July 2016 
 
The HIV/AIDS, STI’s and TB (HAST) Manager 
Ugu Health District Office 
Private Bag X735  
Port Shepstone  
4240 
 
Dear Mrs Cele, 
 
APPLICATION FOR PERMISSION TO CONDUCT A RESEARCH STUDY IN UGU 
DISTRICT 
Research Topic: An Implementation Evaluation Study of A Nurse Initiated and 
Managed Antiretroviral Therapy (Nimart) Program In Primary Health Care Clinics in 
the Ugu district of KwaZulu – Natal. 
I would like to apply for a permission to collect data from the NIMART nurses during the 
Second Quarter NIMART Mentorship Meeting. I’m a lady of 38 years, currently studying 
Masters in Nursing Management – Coursework in the School of Nursing at the University 
of KwaZulu-Natal. Part of the requirements for the Masters Degree is to conduct a 
Research Project. The study of my interest is an Implementation Evaluation Study of 
Nurse Initiated and Managed Antiretroviral Therapy (NIMART) Program in Primary Health 
Care Clinics in the Ugu district of KwaZulu-Natal. Background of this research study is 
based on the presidential mandate announced by President Jacob Zuma during the World 
AIDS day celebration on 1 December 2009. That is, to decentralize HIV treatment to 
primary health care centres with the ultimate goal of universal access to HIV treatment, 
through the Nurse Initiated and Managed Antiretroviral Therapy (NIMART) strategy. 
Objectives of this research study seek to: 
1. Evaluate the availability of latest Antiretroviral Therapy Guidelines in the 
Primary Health Care clinics at Ugu district.  
2. Evaluate the implementation of Nurse Initiated and Managed Antiretroviral 
Therapy (NIMART) program at the clinics in Ugu district. 
3. Evaluate the knowledge and practice of Professional nurses towards NIMART 




Ugu district Primary Health Care clinics from all six sub-districts and two CHC’s will be 
used as the population of this study. All 54 clinics and two CHC’s will be evaluated. 
Professional Nurses that are NIMART trained will be randomly selected from each clinic 
and CHC in all sub-districts. A total of 56 nurses will be participating in this research 
study.  
This research study does not intend to disturb the service deliveryas the participants will 
be completing a Questionnaire with five parts namely: Demographics, Availability of latest 
Antiretroviral Treatment Guidelines, Implementation of NIMART Program, Knowledge of 
NIMART and Practice of NIMART. Completion of the Questionnaire can take only 30 
minutes after the NIMART mentorship meeting. Questionnaire attached please refer to 
Appendix 5. 
I declare that this research project is not sponsored, it is self-funded by the researcher. 
Permission to conduct this research study will be obtained from University of KwaZulu-
Natal Biomedical Research Ethics Committee (UKZN BREC). If you have any concerns or 
complaints regarding ethics issues please contact Ethics Committee (UKZN BREC) at 
(031) 260 4769.  
Please find attached the following:  
A copy of the research proposal including Participant’s information sheet, Informed 
Consent and a Questionnaire. 




Researcher : Mrs Pearl Xaba 
 Work : (039) 688 3000 
 Cell : 083 350 3620 
 Email :pearl.xaba8@gmail.com / pearl.xaba@kznhealth.gov.za  
 
Research Supervisor : Dr J. Kerr  
 Work : (031) 260 1432  
 Email :kerrj@ukzn.ac.za 
 
UKZN BREC Committee : 
Tel: 031 260 4769 





APPENDIX 10: PARTICIPANT’S INFORMATION SHEET 
Date: 1 April 2016 
Dear Participant, 
 
My name is Pearl Xaba, a Masters student from the School of Nursing at the University of 
KwaZulu-Natal, cell: 0833503620 and email address: pearl.xaba8@gmail.com 
 
You are being invited to consider participating in a study that involves research on an 
Implementation Evaluation Study of Nurse Initiated and Managed Antiretroviral Therapy 
(NIMART) Program in Primary Health Care Clinics in the Ugu district of KwaZulu-Natal. 
The aim of this research is to ensure HIV treatment is decentralized to primary health care 
centres with the ultimate goal of universal access to HIV treatment, through the Nurse 
Initiated and Managed Antiretroviral Therapy (NIMART) strategy. The study is expected to 
enrol 56 participants in total, which are NIMART trained Professional Nurses from all the 
54 clinics and 2 CHC’s in Ugu district. It will involve the following procedures, completion 
of a Questionnaire. The duration of your participation if you choose to enrol and remain in 
the study is expected to be one day. The study is self-funded by the Researcher. 
There is no risk of harm to you anticipated in this study as the questionnaire will be 
assessing knowledge of the NIMART Programme and your identity will be anonymous. 
We hope that the study will create the following benefits, identify your gaps in the 
NIMART programme, and action will then be planned to breach those gaps. Hence, 
improve your knowledge and performance. There will be no alternative procedures and 
treatment that may serve as possible alternate options to study participation.  
This study has been ethically reviewed and approved by the UKZN Biomedical research 
Ethics Committee (approval number BE364/16). 
In the event of any problems or concerns/questions you may contact the researcher at 
083 3503620 or the UKZN Biomedical Research Ethics Committee, contact details as 
follows:  
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office, Westville Campus 
Govan Mbeki Building 
Private Bag X 54001 
Durban 
4000 
KwaZulu-Natal, SOUTH AFRICA 
Tel: 27 31 2604769 - Fax: 27 31 2604609 
Email: BREC@ukzn.ac.za 
 
Participation in this research is voluntary and you may withdraw participation at any point, 
and that in the event of refusal/withdrawal of participation the participants will not incur 
penalty or other benefit to which they are normally entitled.  
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There are no costs that might be incurred by participants as a result of participation in the 
study. Participants will not be compensated for participating in this study, since the study 
is not sponsored.  
Participant’s identity will be anonymous to protect confidentiality of personal/clinical 
information. Questionnaires will be kept in supervisor’s office at UKZN to safeguard the 
confidentiality of records and will be restricted to the researcher and statistician.  
You are entitled to keep this copy of the Participant’s Information Sheet. 




APPENDIX 11: INFORMED CONSENT 
I ……………………………………….. have been informed about the study entitled “An 
Implementation Evaluation Study of Nurse Initiated and Managed Antiretroviral Therapy 
(NIMART) Program in Primary Health Care Clinics in the Ugu district of KwaZulu-Natal” 
by the research assistant. 
I understand the purpose and procedures of the study which is completing a 
questionnaire.  
I have been given an opportunity to ask questions about the study and have had answers 
to my satisfaction. 
I declare that my participation in this study is entirely voluntary and that I may withdraw at 
any time without affecting any of the benefits that I usually am entitled to. 
I have been informed that there is no compensation available. 
If I have any further questions/concerns or queries related to the study I understand that I 
may contact the researcher at (039) 6883000 or Cell: 083 3503620 and email address: 
pearl.xaba8@gmail.com 
If I have any questions or concerns about my rights as a study participant, or if I am 
concerned about an aspect of the study or the researchers then I may contact: 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION 
Research Office, Westville Campus 
Govan Mbeki Building 
Private Bag X 54001 
Durban  
4000 
KwaZulu-Natal, SOUTH AFRICA 




____________________      ____________________ 




___________________   _____________________ 
Signature of Witness                                Date 
(Where applicable)     
 
